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ABSTRACT 
 
Besides inducing transcription by activating nuclear receptors, corticosterone 
(CORT) acts rapidly to alter cellular activity through multiple signaling cascades. 
Pharmacology-based experiments presented here show that nanomolar doses of 
CORT activate several pathways in primary hippocampal cultures within 20 
minutes, a time-frame that excludes genomic mechanisms mediated by classical 
glucocorticoid (GR) and mineralocorticoid (MR) nuclear receptors. Moreover, 
none of these effects were subject to inhibition by either a series of structurally-
unrelated antagonists of the classical GR and MR or by inhibitors of translation. 
Accordingly, a major aim of this work was to identify mechanisms proximal to the 
cell membrane that could potentially mediate these rapid actions of CORT. 
 
Initial time-course studies showed that 10 nM CORT rapidly triggers protein 
tyrosine kinase (PTK) activation that can be blocked by the small molecule 
inhibitor, PP2. It was also found that Src kinase is rapidly activated by CORT 
through tyrosine phosphorylation at Y416 and dephosphorylation at Y527. These 
events were subject to regulation by another key PTK member, Pyk2 (proline-rich 
tyrosine kinase 2). A series of experiments designed to study the potential 
mechanisms that regulate Pyk2, revealed that CORT increases the 
phosphorylation status of at least three tyrosine sites within Pyk2, namely, Y402, 
Y579/580 and Y881. Further, pharmacological probing uncovered requisite roles 
for other signaling pathways, such as the classical PLC-PKC pathway and the 
“novel” PKA and PKB pathways.  
 
Interestingly, further investigations revealed that the rapid CORT-induced 
activation of Pyk2/Src occurs in a G-protein dependent manner. This, together 
with the observation that membrane-impermeable BSA-conjugated CORT 
(CORT-BSA) produces similar responses profile to that obtained with CORT, led 
to pilot experiments to probe whether GPR30, a recently-described G protein-
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coupled receptor that appears to transduce signals from other steroid ligands, 
might be the putative receptor for CORT. Support for this view was provided by 
the finding that the rapid actions of CORT and CORT-BSA on Pyk2/Src activation 
could be blocked by a novel inhibitor of GPR30. Nevertheless, further studies will 
be needed to establish the role of GPR30 more firmly. 
 
Other studies sought to identify downstream targets of Pyk2/Src. Results show 
that Pyk2/Src regulates activation of c-Abl (another PTK) and RhoA, both of 
which are regulators of a number of cellular processes, including actin 
cytoskeleton remodeling. Furthermore, it was found that CORT triggers 
phosphorylation of the NR2B subunit of NMDAR, increases surface expression of 
NMDAR and activates downstream MAP kinases; all of these events depend on 
Src, one of whose direct substrates is the NR2B subunit.    
 
In a summary, the evidence presented in this dissertation suggests that, by 
acting via a G protein-coupled receptor, rather than through classical nuclear 
receptor mechanisms,  CORT rapidly activates a series of intracellular signaling 
cascades that lie proximal to the neuronal plasma membrane; Pyk2/Src are early 
kinases involved and beyond these divergent pathways come into play, ultimately 
influencing functions ranging from rearrangements of the actin cytoskeleton, 
spine structure, scaffold protein clustering and function, to synaptic plasticity and 
transcriptional regulation. 
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1. INTRODUCTION 
 
1.1 Corticosteroids 
Corticosteroids are steroid hormones synthesized and secreted by the adrenal 
cortex (Figure 1), and important mediators of homeostatic balance which they 
facilitate by altering glucose mobilization, immune function, and ingestive and 
sexual behaviors, as well as cell (including neuronal) proliferation, differentiation 
and apoptosis (Chrousos and Gold, 1992; Sousa and Almeida, 2002; Riedemann 
et al., 2010). Corticosteroids are small lipophilic molecules which can easily pass 
the blood-brain barrier and reach deep brain tissues such as the hypothalamus 
and hippocampus; both of these areas, but especially the hippocampus, are rich 
in corticosteroid receptors. In this way, corticosteroids can contribute to the 
regulation of emotional and cognitive behaviors, as well as physiological 
processes controlled by the brain. An example of the latter is the regulated 
secretion of corticosteroids through direct actions on neurons in the hippocampus 
and hypothalamus, as will be discussed again later. All neuronal layers of the 
hippocampus (granule and pyramidal) are sensitive to corticosteroids; in the 
hypothalamus, neurons that secrete the neuropeptides corticotrophin releasing 
hormone (CRH) and arginine vasopressin (AVP) into the hypophyseal portal 
system and thus the anterior pituitary,  are particularly sensitive to corticosteroids.  
 
Corticosteroids refer to two distinct classes of adrenal steroids: glucocorticoids 
(GC) and mineralocorticoids (MC). The term glucocorticoid comes from the role 
of these hormones in the regulation of glucose metabolism and the site of their 
synthesis (adrenal cortex). In most mammals, including humans, the predominant 
GC is cortisol. In other species (fish, reptiles, amphibians, birds and rodents), the 
main GC is corticosterone (CORT). GC are best known as “stress hormones” 
because their secretion is increased following the arrival of stressful 
(psychological or physical) stimuli. Mineralocorticoids get their name from the fact 
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that they are important for maintaining physiological levels of salt and water, and 
aldosterone is the most important endogenous MC in all species.  
 
 
 
 
Like most other hormones, GC are secreted according to a robust circadian 
rhythm (in rodents: GC are high during the daily dark period of the light-dark 
cycle; in humans and other diurnally-active species, this pattern is reversed) 
under normal physiological conditions. (Reul et al. 1987; Young et al., 2004; 
Dickmeis et al., 2007).  In the rodent, CORT is released from the adrenal cortex 
in a pulsatile manner, with each pulse lasting approximately 60 minutes; these 
regular pulses give rise to so-called ultradian rhythms upon which the circadian 
rhythm is superimposed (Jasper and Engeland 1991, 1994; Lightman et al., 
2008). Figure 2 illustrates this point but it should be noted that these rhythms 
may be altered according to physiological demands as well as physical or 
psychological stress stimulation.  In addition, GC secretion under both basal and 
stressful conditions are modulated by other factors such as age and gender (van 
Cauter et al., 1996). Interestingly, recent studies have shown ultradian and 
Fig. 1 Schematic representation of steroid biosynthetic pathways. Corticosteroids are 
synthesized from a common precursor hormone pregnenolone, which is produced from 
cholesterol by the cholesterol side chain cleavage. Corticosteroids include mineralocorticoids, 
glucocorticoids and androgens. 17β-HSO = 17β-hydroxysteroid oxidoreductase, 3β-HSD = 
3β-hydroxysteroid dehydrogenase.
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circadian rhythms of CORT in the rat brain, using microdialysis (Droste et al., 
2008, 2009), suggesting that the activity of corticosteroid receptors in the brain 
changes in a rhythmic fashion.  
 
 
 
The top-down control of GC secretion is illustrated in Figure 3 where the 
hypothalamo-pituitary-adrenal (HPA) axis is central. Several brain regions are 
responsible for the positive regulation of adrenal function, but the hypothalamus, 
which communicates with the anterior pituitary (which contains 
adrenocorticotrophic hormone (ACTH)-secreting cells). The central drive on the 
FIG.2 Corticosteroids are secreted rhythmically, displaying ultradian and circadian 
patterns. The circadian peak coincides with the onset of the daily activity cycle (dark phase in 
rodents, light phase in humans). While the physiological and behavioral significance of the 
ultradian rhythms of corticosteroid secretion is still unclear, it is plausible that they serve to 
dynamically fine-tune the regulation of the hypothalamo-pituitary-adrenal (HPA) axis and thus, 
to facilitate adaptive processes. LD: light-dark cycle. (from Riedemann et al. 2010) 
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HPA axis is kept in check through negative feedback loop wherein GC act, in fast 
and slow modes, to inhibit the positive drive from the hypothalamic 
paraventricular nucleus (PVN, site of CRH and AVP neurons).  Brain areas other 
than the hypothalamus that are important for this negative feedback include the 
prefrontal cortex and hippocampus. As already mentioned, maintenance of the 
negative feedback loop is important to regulate neuronal cell birth, differentiation 
and apoptosis, dendritic arborization and synaptic function, and thus, learning 
and memory as well as mood/emotional states (Sousa and Almeida, 2002); thus, 
the regulation of GC is considered highly relevant to a range of neuropsychiatric 
conditions, including anxiety and depression and mild and severe dementia 
(Sotiropoulos et al., 2008).   
 
1.2. Nuclear receptors mediate slow and long-lasting effects of 
corticosteroids 
Transcription-dependent actions of GC that persist (hours to years) have been 
observed at each of the GC feedback target sites of the HPA axis; for example, 
they regulate the expression of ACTH by the at pituitary (Birnberg et al., 1983), 
CRH and AVP in the neurons of the hypothalamus (Sawchenko, 1987), as well 
as GABAergic inhibitory synaptic inputs to CRH neurons of the PVN (Miklós and 
Kovács, 2002). Also, chronic increases of GC have been shown to induce long-
term changes in the excitatory synaptic response properties of hippocampal CA1 
neurons, suggesting their role in enhancing glutamate excitation (Karst and Joëls, 
2005).  
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The best known biological effects of GC depend on gene transcription. When GC 
reach cells, they bind to corticosteroid receptors. These receptors belong to the 
superfamily of nuclear receptors. All nuclear receptors are ligand-activated 
transcription factors. Upon binding ligand (e.g. GC), they translocate from the 
cytoplasm to the nucleus and regulate gene transcription after binding to the 
promoter regions of their target genes. There are two types of corticosteroid 
receptors: glucocorticoid (GR) and mineralocorticoid (MR) receptors. 
Corticosteroids bind to GR with 10-fold lower affinity compared to MR (Reul and 
de Kloet, 1985).  Therefore, GR only become activated when GC levels are high 
FIG.3 The hypothalamic-pituitary-adrenal (HPA) axis is a feedback loop that includes 
the hypothalamus, the pituitary and the adrenal glands. The main hormones that 
activate the HPA axis are corticotropin-releasing hormone (CRH), arginine vasopressin 
(AVP) and adrenocorticotropin hormone (ACTH). The loop is completed by the negative 
feedback of corticosteroids on the hypothalamus and pituitary.  The simultaneous 
release of corticosteroids into the circulation has a number of effects, including elevation 
of blood glucose for increased metabolic demand. Corticosteroids also negatively affect 
the immune system and prevent the release of neurotransmitters. Interference from 
other brain regions (e.g. hippocampus and amygdala) can also modify the HPA axis, as 
can neuropeptides and neurotransmitters. 
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(e.g. during stress) whereas MR are activated by low amounts of GC (e.g. under 
basal conditions). GR also become activated during the daily circadian peak in 
corticosterone secretion (Young et al., 2004). The biological effects mediated by 
GR and MR usually first become manifest after a few hours and all of them 
depend on alterations in protein synthesis. It should be noted that, depending on 
the HPA activity, CORT leads to opposite directions in the cells which express 
both GR and MR, since the activated respective receptors modulate transcription 
of different but overlapping CORT-targets genes via transactivation or 
transrepression (Datson et al., 2008). 
 
Whereas the unliganded MR is mostly localized in the nucleus, unoccupied are 
found in the cytoplasm and translocate to the nucleus after ligand activation. This 
process depends on the dissociation of a host of chaperone and co-chaperone 
molecules such as heat shock protein 90 (HSP), as well as on the inclusion of a 
nuclear translocation signal in the receptor protein (Gronemeyer et al., 2004, 
Duma et al., 2006). Like other nuclear receptors, MR and GR are structured 
according to canonical modules, including a ligand-binding domain (LBD), a 
DNA-binding domain (DBD), and two activation functions (AF-1 and AF-2) at their 
N- and C-terminals, respectively. Interactions of the DBD with hormone-response 
elements (HRE) in the promoters of specific genes result in the induction or 
repression of gene transcription and subsequently, changes in the expression of 
proteins that influence cellular functions.  Classically, the mechanisms of MR and 
GR in the neurons can be regulated in follow levels (Figure 4): 
1. Corticosteroids are carried in the blood, bound to corticosteroid binding 
globulin (CBG); they penetrate into the brain. Endogenous corticosteroids 
are not excluded by the blood-brain-barrier by multiple drug resistance 
(MDR) p glycoprotein in the blood-brain barrier. 
2. Upon entry into the cell and binding to GR, the GR dissociates from 
molecular chaperones (e.g. HSPs and FK506 binding proteins, FKBP),   
leading to conformation change of the receptor (Ratajczak et al. 2003), 
and eventually interactions with other transcription factors (TF) such as 
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nuclear factor-κB (NF- κB) and activator protein 1 (AP1) (De Bosscher et 
al., 2003), before entry into the nucleus. 
3. Within the nucleus, MR and GR interact with co-regulators (co-repressors 
and co-activators) which then help induce, repress or transactivate gene 
expression (Privalsky, 2004; Rosenfeld et al., 2006). 
 
 
 
 
The MR and GR regulate the adaptive behavioral responses by altering the 
expression of related genes since both of them function as transcriptional 
regulators. Although the DBD of both MR and GR are highly conserved, the 
Fig. 4 Classical mechanisns of action of nuclear MR and GR. The MR or GR multimeric 
protein complex dissociates after binding corticosteroids. For the effects on gene expression, 
MR and GR functioning either as homodimers or heterodimers, interact at a hormone-response 
element (HRE) and recruit co-regulators, whereas GR monomers interact with stress-induced 
transcription factors to translocate into nucleus. CS: corticosteroids. HSP: heat shock protein.  
FKBP: FK506 binding protein. NF- κB: nuclear factor-κB. AP1: activator protein 1. HRE: 
hormone-response element. TF: transcription factors. 
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genes to which they bind are not necessarily identical. Studies using serial 
analysis of gene expression (SAGE) in rat hippocampus, showed that CORT 
regulates the activation or repression of 203 responsive genes in a coordinated 
manner via MR and GR. 48% of these genes are responsive to MR, 35% are 
responsive to GR and only 16% are responsive to both receptors (Datson et al. 
2001). These investigations suggest that both corticosteroids receptor mediate 
the expression of multiple genes whose function ranges from energy expenditure 
and cellular metabolism to protein synthesis and turnover, signal transduction 
and neuronal connectivity and synaptic transmission.  
 
 
1.3. Corticosteroid actions are not solely mediated by nuclear 
receptors 
Besides the genomic response, steroid hormones, including MC and GC have 
been recognized to exert rapid actions on cells from multiple organisms for long 
time. Such rapid actions have been well described for estrogens and, to some 
extent, progestins (Genazzani et al., 2000; Belcher and Zsarnovszky, 2001; Levin, 
2008). The latter and their derivatives, for example, influence neuronal activity by 
interacting with an allosteric binding site on γ-aminobutyric acid type A (GABAA) 
receptors located at the cell membrane (Frye and Walf, 2008). Estrogens have 
also been shown to act at mitochondrial and/or plasma membranes. These will 
be discussed in greater detail in the following section.  
 
Interestingly, GC also exert acute effects and can act to rapidly to suppress HPA 
axis activation. For example, GC suppress CRH-induced ACTH secretion within 
minutes via a rapid and transcription-independent mechanism in the pituitary 
(Hinz and Hirschelmann, 2000).  In the hypothalamus, GC have been reported to 
exert rapid inhibitory effects on spiking activity in PVN neurons (Chen et al., 
1991), and to suppress stimulated AVP release, also via a transcription-
independent mechanism (Liu et al., 1995). In the hippocampus, GC are reported 
to induce rapid, transcription-independent increases in glutamate release onto 
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CA1 pyramidal neurons, resulting in an increase of excitatory synaptic inputs, an 
effect that is thought to involve intracellular MC receptors (Karst et al., 2005).   
 
GC have also been shown to rapidly enhance the functional expression of long-
term potentiation (LTP) in the CA1 pyramidal cell layer; however, this can 
reportedly occur through mechanisms which are independent of the activation of 
both classical GC and MC receptors (Wiegert et al., 2006). Accompanying the 
emerging evidence described, the hippocampus, which contains the highest 
levels of receptors for corticosteroids, is becoming one of the best studied brain 
regions and a target for investigations of how fast adjustments in the activity of 
the HPA might occur. Since some neuropsychiatric diseases (e.g. anxiety, 
depression and Alzheimer’s disease) are associated with impaired GC feedback 
actions (resulting in hypersecretion of GC, Sotiropoulos et al., 2008), more and 
more attention is being paid to the GC responses in the hippocampus. The 
importance of such studies in the hippocampus will be described in greater detail 
in Section 1.5. 
 
1.4. Rapid actions of glucocorticoids 
Steroids have been known for decades to trigger rapid responses (almost for as 
long as their nuclear receptor-mediated responses have been known). 
Corticosteroids, and especially GC, have been observed to exert a wide range of 
rapid functional effects on different cells and tissues (muscle, pancreas, heart, 
adipose tissue, the immune system and brain) as well as on behavioral 
responses in different vertebrate species. Some of the rapid, transcriptional-
independent GC effects in tissues other than the central nervous system (CNS) 
are listed in Table 1; these studies indicated that the fast responses of GC in 
many organisms occur independently of, or simultaneous with, the transcriptional 
regulatory function of genomic GR. The use of membrane-impermeable GC 
preparations (e.g. bovine serum albumin conjugated to corticosterone, CORT-
BSA) has played an important part in supporting the idea that GC can act at the 
cell membrane without penetration to access classical intracellular receptors. 
INTRODUCTION 
 - 14 -
Table 1. Examples of rapid glucocorticoids actions in non-neural tissues. 
 
In the CNS, GC have been found to exert effects on neuronal activity that can 
occur within seconds-to-minutes of exposure of cells to the steroids, whereas 
gene transcription and translation require at least 20-30 minutes or even longer 
for their effects to be apparent. Table 2 shows some rapid GC-induced 
behavioral responses and physiological effects in different brain areas. These 
rapid effects of GC on brain function, often involving changes in structure, cannot 
be accounted for by transcriptional activation and are therefore referred to “non-
genomic” effects (de Kloet et al. 2008; Riedemann et al. 2010).  
Tissue/System Rapid effects Reference 
Trachea Inhibit smooth muscle contraction via 
rapid actions that are not blocked by 
GR antagonist RU38486. 
 
Sun et al., 2006 
Pancreatic β-cells Cause a rapid suppression of the 
stimulated release of insulin, which is 
opposite to the delayed increase in 
insulin levels caused by slow 
glucocorticoids actions. 
 
Sutter-Dub, 2002 
Heart Induce endothelial nitric oxide release 
by stimulating nitric oxide synthase 
via PI3K and PKB pathway.  
 
Hafezi-Moghadam et al., 2002 
Adipose tissue Stimulated fat cell production by 
facilitating the differentiation of 
preadipocyte precursors into 
adipocytes via a non-transcriptional 
suppression of a histone deacetylase 
complex.   
 
Wiper-Bergeron et al., 2003 
Immune system The anti-inflammatory effects of 
glucocorticoids are partly independent 
of GR binding to DNA, indicating a 
non-transcriptional action. 
Reichardt et al., 2001 
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Table 2. Rapid behavioral and physiological effects of glucocorticoids in the central 
nervous system.  (Adapted from Riedemann et al. 2010) 
 
Parameters Rapid effects Reference 
Locomotion 
 
Increased locomotion in novel 
environment which is independent on 
protein synthesis and mediated by nitric 
oxide.  
Sandi et al. 1996a, 1996b 
Aggressive behavior Increased aggression in resident-intruder 
paradigm which is independent on protein 
synthesis 
Mikics et al. 2004, 2007 
Anxiety, risk-taking 
behavior 
Increased risk assessment, but no 
anxiety-related behavior  which is 
independent on protein synthesis 
Mikics et al. 2005 
Enhanced taste conditioning  Kent et al. 2000 
Impaired retrieval contextual memory  Roozendaal et al. 2004 
Impaired memory in water maze task 
which is insensitive to transcriptional 
inhibition 
Sajadi et al. 2006 
Impair memory retrieval via  MR 
mediation which is independent on protein 
synthesis 
Khaksari et al. 2007 
Learning and memory 
 
Impaired memory retrieval by acute stress 
which is mediated by putative membrane 
receptor 
Chauveau et al. 2010 
Increased extracellular dopamine levels in 
nucleus accumbens via reward-
motivational pathway 
Piazza et al. 1996 
Increased NMDA-mediated firing of 
dopaminergic neurons in ventral 
tegmental area via reward-motivational 
pathway via GR 
Cho and Little 1999 
Increased spike frequency in locus 
coeruleus neurons 
Avanzino et al. 1987 
Inhibition of catecholamine uptake Gründemann et al. 1998 
Neurochemical 
 
Increased p38 and JNK and ERK1/2 
activation in PC12 cell line  which is GR-
independent 
Qiu et al. 2001 
Li et al. 2001 
Triggers fast glucocorticoid negative 
feedback 
Dallman et al. 1969 
Inhibits neuron firing rate in hypothalamic 
paraventricular nucleus  
Kasai and Yamashita 1988 
Neuroendocrine regulation 
Reduces excitatory glutamatergic input to 
PVN and increases endocannabinoid 
release via GPCR and retrograde 
endocannabinoid signaling 
Di et al. 2003 
Tasker et al. 2006 
Suppress mEPSC  in hypothalamus via 
GPCR 
Di et al. 2003 
Increase mEPSC in hippocampus via 
membrane MR 
Karst et al. 2005 
Suppress NMDA-dependent current via 
putative membrane receptors  
Sato et al. 2004 
Liu et al. 2007 
Electrophysiology 
Increase NMDA-dependent neurotoxicity 
through the mediation of MAPK and  
membrane receptors  
Xiao et al. 2010 
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Rapid GC actions have been shown to be mediated by multiple signal 
transduction pathways, such as guanosine triphosphate (GTP) -binding protein 
(G-protein) (Ffrench-Mullen, 1995; Qi et al., 2005; Hu et al., 2010), adenylyl 
cyclase (AC) (Kageyama et al., 2010), protein kinase C (PKC) and A (PKA) (Qiu 
et al., 2003a; Han et al., 2005; Qi et al., 2005),  phosphatidylinositol-3-kinase 
(PI3K) (Hafezi-Moghadam et al., 2002), protein tyrosine kinase (PTK) and protein 
tyrosine phosphatases (PTP) (Nestler et al., 1989; Tian et al., 1998), nitric oxide 
synthase (NOS) (Sandi et al., 1996b; Hafezi-Moghadam et al. 2002), and 
mitogen-activated protein kinase (MAPK) (Qiu et al., 2001; Li et al., 2001; Qi et 
al., 2005; Xiao et al., 2005). These signaling pathways are located in the 
cytoplasm, some of them close to the plasma membrane; some are rapidly 
activated and eventually, many of their effects converge in the nucleus to 
regulate gene transcription and protein synthesis.  
 
1.4.1. Rapid actions mediated by membrane receptors 
G-protein-coupled receptors (GPCR) are the largest family of cell surface 
molecules involved in signal transduction; they mediate multiple sensory and 
chemical stimuli (such as odorants, light, neurotransmitters, hormones, ions), 
share a highly conserved backbone structure of a seven-transmembrane domain 
(Müller, 2000), and correspond to around 1-5% of protein content of the cell. 
Thus, GPCR are intensively investigated in pharmacology, especially in the CNS 
(Pierce et al., 2002). GPCR interact with G-proteins and activate downstream 
signaling cascades through well-studied mechanisms (Hur and Kim, 2002). Their 
binding with extracellular ligands causes conformational changes in their seven-
transmembrane domains which, in turn, cause changes in the conformation of 
GPCR intracellular domains. These changes induce the specific association of 
the GPCR with distinct classes of heterotrimeric G-proteins composed of three 
subunits: the α-subunit that has a guanine-nucleotide binding site and GTPase 
activity, and the β- and γ-subunits that form a tightly-bound dimmer. Based on 
their amino acid similarities, G-protein α-subunits are further classified into four 
families: Gs, Gi/o, Gq/11, G12. In general, stimulation of Gs activates AC and 
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voltage-sensitive calcium channels (VSCC), whereas stimulation of Gi/o leads to 
inhibition. Stimulation of Gq/11 activates phospholipase C (PLC), and G12 is known 
to regulate small G-proteins and non-receptor tyrosine kinases. 
 
Studies have shown that rapid GC effects are mediated, at least partly, by GPCR 
and their downstream intracellular signaling cascades in CNS. For example, GC 
were shown to trigger the effects of VSCC in hippocampal and dorsal root 
ganglion via a G-protein dependent mechanism (Ffrench-Mullen 1995; He et al., 
2003). Further, GC inhibit ACTH release from AtT20 cells, a pituitary tumor-
derived cell line, through a non-genomic mechanism that is blocked by pertussis 
toxin (PTX), a drug that specifically interferes with receptor coupling to most 
family members Gi/o type G-proteins, indicating involvement of Gi/o in mediation of 
the GC effects (Iwasaki et al. 1997). In addition, rapid GC effects have been 
shown to be dependent on activation of Gs in rat hypothalamic PVN neurons, 
suggesting that GC can positively regulate cyclic adenosine monophosphate 
(cAMP) production (Malcher-Lopes et al., 2006).   
 
It is worth noting that the rapid and transcription-dependent effects of GC are 
very likely mediated not only by GPCR, but also by the classical intracellular 
corticosteroid receptors (GR and MR) or other putative receptors that are 
somehow linked with the plasma membrane. For example, one of the best 
studied steroid hormone receptors, the nuclear estrogen receptor (ER), or 
fragments thereof, appears to be present in the plasma membrane of multiple cell 
lines or tissues, including neuronal cells (Micevych and Dominguez, 2009). 
These immunoreactive ER are primarily associated with caveolae, invaginations 
of the plasma membrane (Razandi et al., 2002) composed of scaffolding proteins 
that associate with various signaling molecules, such as GPCR and Src, to 
facilitate rapid signal transduction (Cohen et al., 2004). Caveolin-1, a ubiquitously 
expressed caveolin, has been recently shown to regulate rapid signaling through 
binding of ER at the plasma membrane (Sud et al., 2010). Binding of caveolin-1 
has also been suggested to be important for membrane translocation of other 
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steroid receptors (Lu et al., 2001; Pedram et al., 2007). In mouse hypothalamic 
neurons, nuclear ER have been reported to mediate rapid responses to estrogen 
in a G-protein dependent manner and via PKC/PKA signaling (Qiu et al., 2003b). 
On the other hand, some authors have suggested that the putative membrane 
ER-mediated rapid cell signaling may be a distinct GPCR that is intracellularly 
located on the endoplasmic reticulum membrane (Revankar et al., 2005). 
However, the question of whether the rapid estrogen effects are mediated by a 
separate GPCR or by classical intracellular (nuclear) receptors that directly 
associate with the plasma membrane remains open (Pedram et al., 2006).  
 
The classical (nuclear) GR was reported, using electron and confocal microscopy, 
to be located on the membrane of rat neuronal cells where it was proposed to 
participate in signal transduction both at the cell membrane and nucleus (Liposits 
and Bohn, 1993; Johnson et al., 2005). However, questions still arise as to 
whether the rapid effects of GC could be mediated by classical intracellular 
receptors and about whether a nuclear receptor can indeed directly associate 
with elements of plasma membrane. At the same time, there are reports that the 
rapid GC-induced increase of glutamate miniature excitatory postsynaptic 
currents (mEPSCs) in hippocampal CA1 pyramidal neurons can be blocked by 
antagonist of intracellular MR, but not nuclear GR antagonists (e.g. RU38486 or 
mifepristone) (Karst et al., 2005). The same authors provided further evidence for 
mediation by the classical MR in that they failed to see GC modulation of 
mEPSCs in MR knock-out mice (Karst et al., 2005). Contrary to the suggested 
mediation of the rapid actions of GC by nuclear MR, other authors have proposed 
a role for classical GR. For example, while it was found that plasma membrane-
impermeable CORT-BSA can enhance memory consolidation and impair working 
memory via a G-protein dependent mechanism, the actions of CORT-BSA were 
blocked by a GR, but not MR, antagonist (Barsegyan et al., 2010). Further 
support for GR involvement in the fast actions of GC comes from studies with the 
synthetic GR agonist dexamethasone (DEX): DEX was found to rapidly modulate 
the density and morphology of dendritic spines in CA1 pyramidal neurons in the 
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rat hippocampus, apparently mediated by postsynaptic GR in triton-insoluble 
synaptosomal fractions (Komatsuzaki et al., 2005).   
 
Next, some of the possible membrane-proximal signaling molecules that could 
potentially mediate the fast actions of GC on neuronal function will be reviewed 
briefly as these will be considered in the Results section (Chapter 4) of this 
thesis.  
 
1.4.2. Protein tyrosine kinase and phosphatase 
Protein tyrosine kinases (PTK), including receptor tyrosine kinases (RTK) and 
non-receptor tyrosine kinases (NRTK), play an important role in the control of 
many fundamental cellular processes, such as cell cycle control, migration, 
metabolism and survival, as well as proliferation and differentiation, in multiple 
tissues and organs, including the CNS (Hubbard and Till, 2000).   
 
RTK are a large family of transmembrane receptors that possess intrinsic 
tyrosine kinase activity. All of them contain an extracellular ligand-binding domain 
which is connected to the cytoplasmic domain by a single transmembrane helix. 
The cytoplasmic domain contains a conserved PTK sequence and additional 
regulatory sequences that are themselves subject to auto-phosphorylation and 
that can be phosphorylated by other protein kinases (Hubbard et al., 1998). 
Almost all known RTK, except for the insulin receptor, exist as monomers in the 
cell membrane; examples of these are neurotrophic tyrosine receptor kinases 
(Trk), fibroblast growth factor (FGF) receptor, epidermal growth factor (EGF) 
receptor and platelet-derived growth factor (PDGF) receptor. Ligand binding 
induces dimerization of these receptors, resulting in autophosphorylation of their 
cytoplasmic domains which, in turn, activate various downstream signaling 
pathways (Jiang and Hunter, 1999).  
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NRTK are intracellular tyrosine-specific protein kinases which recruit activities to 
the plasma membrane but lack intrinsic kinase function. Most NRTK associate 
with subcellular structures permanently or transiently on the cytoplasmic side of 
the plasma membrane. These properties allow NRTK to play a role as 
intracellular effector molecules and to participate in fast signal transduction, 
either by receiving signals from activated membrane receptors or transmitting 
signals on to membrane-associated proteins, following phosphorylation or 
dephosphorylation of specific tyrosine residues. Thus, it is reasonable to assume 
that NRTK may play an important role in the mechanisms of rapid GC-induced 
actions. Three NRTK are particularly relevant to this thesis: sarcoma tyrosine 
kinase (Src), proline-rich tyrosine kinase 2 (Pyk2) and Abelson tyrosine kinase 
(Abl) (see later sub-sections).   
 
Protein tyrosine phosphatase (PTP) is expressed in a wide variety of cell types 
and is an efficient regulator of cell adhesion, spreading and migration. PTP play a 
crucial role in modulating the activity of PTK and their subsequent signaling 
pathways.  Like PTK, PTP are a structurally diverse family of enzymes including 
receptor-type and soluble-type forms which contain a highly-conserved catalytic 
domain and unique non-catalytic segments. This structural diversity reflects 
differences in the regulation and function of each enzyme. It has been reported 
that the activation of PTP controls cytoplasmic protein tyrosine phosphorylation to 
regulate PTK signaling pathways. Although the activity of RTK is down-regulated 
by the activation of PTP, PTP can exert a positive regulatory function in signal 
transduction through cleavage of the inhibitory phosphate residue of NRTK, such 
as the tyrosine phosphorylation site (Y) 527 of Src tyrosine kinase. 
 
1.4.3. Src kinase 
Src, a member of NRTK, has been studied as a proto-oncogene since its 
discovery in the chicken tumor-causing Rous sarcoma virus by the Nobel Prize 
winner Peyton Rous in 1911 (Roskoski, 2004). In the last decades, attention has 
been paid to Src, particularly investigations of its effects in the CNS. Src has 
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been shown to play an important role in neuronal differentiation and neurite out-
growth, as well the regulation of ion channel activity, synaptic transmission, and 
N-methyl D-aspartate receptor (NMDAR)- dependent synaptic plasticity (Salter 
and Kalia, 2004). Much evidence indicates that Src may be involved in learning 
and memory, pain, epilepsy and neurodegeneration by serving as the signal 
transduction convergence point for pathways related to GPCR, RTK and cell 
adhesion receptors (Roskoski, 2004.).  
 
Src is the prototype of the Src family of kinases (SFK) which is the largest family 
of mammal PTK. Five SFK members have been reported to be expressed 
throughout the mammalian CNS: Src, Fyn, Yes, Lck and Lyn (Salter and Kalia, 
2004). All of these are proteins of 52-62 kDa in size that share a common domain 
structure (Figure 5), including a catalytic domain, the Src homology (SH) 2 
domain and the SH3 domain. The catalytic domain exerts tyrosine kinase activity 
and contains the activation loop which embraces an auto-phosphorylation 
tyrosine residue that is important for the regulation of kinase activity. The SH2 
domain has been found in many other PTK and contains around 90 amino acids 
which bind to specific peptide motifs such as phosphorylated tyrosine. The SH3 
domain also mediates protein-protein interactions and contains only 60 amino 
acids which canonically bind to proline-rich sequences. Besides these highly- 
homologous domains, the SH4 domain shared by SFK members, albeit with 
lower homology, contains about 15 amino acids at the N-terminal that are 
important for anchoring the protein to cell membranes. A unique domain that 
exists between the SH3 and SH4 domains is a region with variable size and 
which shows poor conservation among SFK members.  
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The catalytic activity of Src is dynamically mediated through the intramolecular 
interactions of the SH2 and SH3 domains and through the phosphorylation and 
dephosphorylation of the tyrosine kinase target sites, such as the tyrosine sites 
Y416 and Y527. As shown in Figure 5, under basal conditions, Src is inactivated 
and the Y527 of Src is phosphorylated by several PTK, such as the C-terminal 
Src kinase (Csk) and Csk homologous kinase (Chk). Src kinase activity is 
suppressed by intramolecular interactions, such as that of phosphorylated Y527 
with the SH2 domain and SH3 domain within the linker region; this interaction 
provides the activation loop and embraces the autophosphorylation site Y416. 
Thus, at least two mechanisms are responsible for the activation of Src: the 
dephosphorylation of Y527 by kinases such as PTP, and the displacement of the 
intramolecular interaction by binding of SH2 and/or SH3 domain with other PTK. 
Both of these conformations lead to autophosphorylation of Y416, resulting in the 
full activation of Src kinase. Other modulators have also been shown to regulate 
Src kinase activity by interactions with the catalytic domain, e.g. the small 
Figure 5. Structure and activation of Src family kinases (SFK). A: Members of SFK share a 
common domain structure which contains Src homolgy (SH) 4 domain, unique domain, SH3 
domain, SH2 domain, linker region, and catalytic domain. The activation of Src is mediated by 
intramolecular interactions and tyrosine phosphorylation or dephosphorylation at tyrosine sites 
of kinase, such as the Y416 site in catalytic domain and Y527 in the C-terminal region. B: In the 
inactive conformation, the SH2 domain interacts with phosphorylated Y527 in the regulatory 
domain, the SH3 domain interacts with a ligand in the linker region, and autophosphorylation 
siteY416 in the activation loop is dephosphorylated. By convention, the amino-acid residue 
numbers shown are relative to chicken Src.  
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molecule inhibitor (4-amino-5-(4-chlorophenyl)-7-(dimethylethyl) pyrazolo [3,4-
d]pyrimidine) PP2 (Hanke et al., 1996) and intracellular Gi-proteins (Ma et al., 
2000). 
 
In the CNS, an important function of SFK members is the regulation of ion 
channels activity, e.g. NMDA receptors (NMDAR) (Salter, 1998), VSCC (Cataldi 
et al., 1996), GABAA receptors (Moss et al., 1995), and nicotinic acetylcholine 
receptors (Wang et al., 2004). The NMDAR has been shown to participate in fast 
excitatory synaptic transmission via mechanisms mediated by SFK throughout 
the CNS. For example, Src has been shown to associate with and to upregulate 
the activity of the NMDAR in the hippocampus and spinal cord (Yu et al., 1997); 
moreover, Src-mediated upregulation of NMDAR induces LTP in the CA1 region 
of the rat hippocampus (Lu et al., 1998). More detailed information about NMDAR 
and its downstream pathways will be described later in this chapter. 
 
1.4.4. Proline-rich tyrosine kinase 2 
The proline-rich tyrosine kinase 2 (Pyk2), also known as related adhesion focal 
tyrosine kinase (RAFTK), cell adhesion kinase beta (CAK-β), calcium-dependent 
tyrosine kinase (CADTK) and focal adhesion kinase 2 (FAK2), has been 
identified as a member of focal adhesion kinase (FAK) family of NRTK (Avraham 
et al., 1995). Both members of the FAK family, FAK and Pyk2, have molecular 
masses that range between 110 and 125 kDa and exhibit approximately 48% 
amino acid identity over the length of the molecule. Although structural similarity 
exists, FAK and Pyk2 display significant different properties. For example, FAK is 
ubiquitously expressed whereas Pyk2 is mainly expressed in the CNS and in 
cells of the hematopoietic lineage (Avraham et al., 2000). While FAK is localized 
to focal adhesion sites in adherent cells, Pyk2 is mainly distributed throughout the 
cytoplasm and enriched in perinuclear regions (Schaller and Sasaki, 1997). 
These facts suggest that FAK and Pyk2 interact with different proteins and 
regulate different signaling pathways.  
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Although its detailed structure has not been fully characterized as yet, several 
functional domains of Pyk2 have been identified and characterized. As shown in 
Figure 6, these functional domains include an N-terminal band 4.1-ezrin-radixin- 
moesin (FREM) domain, a central tyrosine kinase domain, several proline-rich 
sequences and C-terminal focal adhesion targeting (FAT) domain. FREM 
domains are tight cloverleaf-shaped structures composed of three structural 
modules which mediate both protein-membrane targeting and protein-protein 
interactions to regulate Pyk2 function. It has been reported that Ca2+/calmodulin 
induces Pyk2 activation directly or indirectly; this effect is abolished by mutations 
in the FREM domain, suggesting a role of the FREM domain in mediating 
Ca2+/calmodulin binding (Kohno et al., 2008).  
 
 
 
 
 
The central catalytic domain, which exerts tyrosine kinase activity, is connected 
to the FREM domain by a short linker segment which contains an auto-
phosphorylation tyrosine site Y402. Phosphorylation at Pyk2 Y402 activates Src 
kinase by binding with the SH2 domain of Src to interfere with its intramolecular 
binding with phosphorylated Y527 of Src. The binding with Src results in the 
phosphorylation of Y579/Y580 in the Pyk2 catalytic domain to maximize Pyk2 
activation through mechanisms that remain unclear (Park et al., 2004). The 
catalytic domain is followed by two proline-rich sequences which mediate the 
interaction of Pyk2 with proteins that contain SH3 domain. Notably, mutations of 
Figure 6. Schematic diagram of Pyk2 structure and its functional domains. Pyk2 contains 
an N-terminal band 4.1, ezrin, radixin, moesin (FERM) domain, a central tyrosine kinase 
domain, proline-rich motifs and a C-terminal focal adhesion targeting (FAT) domain. The 
phosphorylation of Y402 induces the binding with Src resulting in the phosphorylation of 
Y579/Y580 in the kinase domain, and the phosphorylation of Y881 in the FAT domain. Proline 
rich motifs (in green) mediate interaction with various proteins contained SH3 domain. The 
relative length of the domains and the positions of tyrosine sites are drawn to scale.   
FERM Kinase FAT NH2 
Y402 Y579 Y580 Y881 
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proline-rich sequences in Pyk2 have been reported to have an exclusively 
nuclear localization, suggesting a potential role of Pyk2 in nucleus-located 
processes such as transcriptional regulation (Aoto et al., 2002). The C-terminal 
FAT domain of Pyk2 which is conserved with the corresponding FAT domain 
within FAK, which is necessary and sufficient for effective localization to focal 
adhesions, and has been reported to mediate the interactions with various 
proteins resulting in regulation of multiple cellular functions, such as actin 
cytoskeleton organization (Wang et al., 2003a) and scaffold protein function (Lulo 
et al., 2009). The phosphorylation site Y881 of Pyk2 locates to the FAT domain 
which binds to growth factor receptor-bound protein 2 (Grb2) after 
phosphorylation, and subsequently regulates downstream mitogen-activated 
protein kinase (MAPK) signaling pathways (Blaukat et al., 1999).  
   
Over the last years, the role of Pyk2 in the CNS, especially in the hippocampus, 
has been intensively studied. It has been observed that the mechanisms of 
GPCR-activated MAPK signaling pathways are linked to activation of Pyk2 and 
Src via Gi- and Gq-coupled receptor dependent pathways in PC12 cells, a cell 
line derived from a pheochromocytoma of the rat adrenal medulla and which 
exhibits neuronal properties when differentiated with (and maintained in) nerve 
growth factor (Dikic et al., 1996). Depolarization-induced activation of Pyk2, Src 
and ERK in a Ca2+- and PKC-dependent manner have also been reported in rat 
hippocampal slices (Corvol et al., 2005). Activated Pyk2 has been reported to 
induce LTP which depends on downstream activation of Src to upregulate 
NMDAR in the CA1 region of the rat hippocampus (Huang et al., 2001); that 
observation suggests that the connection between Pyk2 with NMDAR might be 
linked by postsynaptic density protein 95 (PSD-95), one of the most prominent 
scaffolding proteins at postsynaptic sites, through the binding the SH3 domain of 
PSD-95 to the proline-rich region of Pyk2 (Seabold et al., 2003). A recent study in 
the CA1 region of the rat hippocampus indicated that NMDAR-mediated Ca2+ 
influx induces postsynaptic clustering and transactivation of Pyk2 by PSD-95 
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binding; further, this work suggested PKC involvement in this event, as well as 
pointing to a critical role of Pyk2 in learning and memory (Bartos et al., 2010). 
 
1.4.5. Abelson tyrosine kinase 
The Abelson tyrosine kinases (Abl) belong are NRTK and consist of c-Abl (also 
known as ABL1) and Arg (Abl-related gene, also known as ABL2), which are the 
only two known tyrosine kinases that directly interact with the cytoskeleton. Since 
the genes of Abl were first identified as proto-oncogenes from Abelson murine 
lymphosarcoma virus (Abelson and Rabstein, 1970), the signaling functions of c-
Abl and its oncogenic fusion with the breakpoint-cluster region (BCR)-Abl have 
been extensively studied. c-Abl is ubiquitously expressed in vertebrates and has 
been found in several subcellular sites, including the nucleus, cytoplasm, 
mitochondria and endoplasmic reticulum where c-Abl interacts with multiple 
cellular proteins including PTK and PTP, cell-cycle regulators, transcription 
factors and cytoskeleton proteins, to mediate various cellular processes, e.g. 
regulation of cell growth and survival, oxidative stress and DNA-damage 
responses, actin dynamics and cell migration (Smith and Mayer 2002; Colicelli 
2010).  
 
As shown in Figure 7, like Src kinase, c-Abl contains a SH3, SH2 and catalytic 
domains; the latter includes an activation loop and exerts tyrosine kinase 
activities. Structurally, Abl and Src share 37% identity between their SH3 and 
SH2 domains and 52% identity in their catalytic domains (Nagar et al., 2003) and 
they both can auto-inhibited through intramolecular interactions (e.g. binding of 
SH3 domain with linker region and SH2 domain with C-terminal lobe of the 
kinase domain). The N-terminal of c-Abl contains a “Cap” region, equivalent to 
the unique domain of Src, which has different splice variants.  The unique 
structure of c-Abl is its long C-terminal extension, also known as the last exon 
region, which contains various sites of interaction, including proline-rich motifs, a 
DNA-binding site, a globular (G)- and filamentous (F)-actin binding site, 
accounting for the diverse subcellular localization and specific functions of the 
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protein, such as the regulation of F-actin cytoskeleton in eukaryotic cells 
(Woodring et al., 2003). The last exon region has been reported to regulate 
tyrosine phosphorylation as well as activity of other cellular proteins (Hantschel 
and Superti-Furga, 2004).  
 
 
 
 
 
Nine tyrosine phosphorylation sites have been identified in Abl by mass 
spectrometry (Steen et al., 2003). Two of these have received considerable 
attention since they have been correlated with increased c-Abl kinase activity: 
Y245, which resides in the linker region between the SH2 and kinase domains, 
and Y412, which resides in the activation loop of the kinase domain.  The c-Abl 
kinase is activated by the auto-phosphorylation of kinase domain tyrosine 
residues in trans or by other protein kinases such as Src kinase. Phosphorylation 
of Y245 and Y412 are required for full kinase activation (Brasher and Etten, 2000; 
Tanis et al., 2003) of Abl. Furthermore, SFK-induced phosphorylation of Y89, 
which lies in the SH3 domain of c-Abl, has been reported to prevent the 
intramolecular binding of the c-Abl SH3 domain with the linker region, resulting in 
enhancement of c-Abl kinase activity and subsequent cellular signaling (Chen et 
al., 2008). 
 
The pharmacological compound STI-571 (imatinib mesylate), also known as 
Gleevec®, is a 2-phenyl-amino-pyrimidine derivative which shows very high 
affinity and specificity for Abl tyrosine kinase, originally designed to inhibit the Abl 
Figure 7. Schematic representation of the structure of c-Abl and its functional domains.  
c-Abl contains a “cap” region in N-terminal, SH3 domain, SH2 domain and a central tyrosine 
kinase domain. The last exon region follows the kinase domain in C-terminal extension, 
including proline-rich motifs, DNA binding domain (DBD), G-actin binding domain (GBD) and 
F-actin binding domain (FBD). Only tyrosine sites of Y89 in SH3 domain, Y245 in linker region 
and Y412 in the activation loop of kinase domain are shown.   
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protein tyrosine kinase for the treatment of BCR-Abl positive leukaemias (Druker 
et al., 1996). STI-571 binds to the kinase domain of Abl and forces it into an 
inactive and non-phosphorylable conformation. Although the sequences of the 
kinase domain are highly conserved between c-Abl and Src, STI-571 was found 
to inhibit the catalytic activity of c-Abl, but not that of Src (Nagar et al., 2003), 
making this drug an effective tool to study the cellular functions of Abl tyrosine 
kinase.  
 
There are emerging evidences that suggest that Abl family kinases are important 
in diverse contexts in CNS development and function. For example, genetic 
studies showed that Abl is required for the proper morphogenesis of most 
neurons in the developing nervous system of fruit flies (Gertler et al., 1989).  In 
vertebrates, c-Abl has been implicated in different neuronal process, such as 
neurite outgrowth and synaptic function (Moresco and Koleske, 2003).  It was 
shown that the activation of c-Abl induces the phosphorylation of cyclin-
dependent kinase 5 (Cdk5), which is a small serine/threonine kinase that plays a 
crucial role during development of the CNS, e.g. in promoting neurite outgrowth 
(Zukerberg et al., 2000).  Abl-induced neurite outgrowth has also been observed 
to occur through a Rho-dependent pathway in cultured hippocampal neurons 
(Jones et al., 2004). Other work has reported that c-Abl localizes to the 
presynaptic terminals and dendritic spines of neurons in the CA1 region of the 
mouse hippocampus where it regulates neurotransmitter release at Schaffer 
collateral-CA1 synapses (Moresco et al., 2003).  c-Abl is reportedly activated by 
the PDGF receptor, a RTK that regulates various signal transduction pathways in 
hippocampal neurons in a Src-dependent manner, serving to regulate changes in 
the neuronal cytoskeleton which eventually influence NMDA receptor signaling 
(Beazely et al., 2008). One recent study has shown that c-Abl regulates synapse 
formation by mediating tyrosine phosphorylation and clustering of the scaffold 
protein PSD-95 in the post-synaptic density of rat hippocampal neurons (de Arce 
et al., 2010). Together, these results suggest an important role for Abl kinases in 
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linking signal transduction pathways that induce cytoskeletal rearrangement with 
the regulation of neuronal morphogenesis and synaptic function.   
 
1.4.6. Other mechanisms related to this study 
PTP-PEST 
Protein tyrosine phosphatase (PTP) plays just a crucial role as PTK in the 
regulation of cellular tyrosine phosphorylations. The proline-, glutamic acid-, 
serine- and threonine-rich (PEST) family of PTP is a soluble-type PTP and 
contains three intracellular phosphatases: PTP-PEST, proline-enriched 
phosphatase (PEP)/lymphoid tyrosine phosphatase and PTP-hematopoietic stem 
cell fraction. All family members reside in the cytoplasm and share a common 
domain structure, including N-terminal catalytic domain, several proline-rich 
motifs and a conserved C-terminal tail. Unlike other members of the family whose 
expression is restricted in immune and hematopoietic cells, PTP-PEST is 
ubiquitously expressed in various cell types, including neurons (Veillette et al., 
2009). Two serine residues, (S) 39 and S435, are the major phosphorylation sites 
of PTP-PEST. The phosphorylation of PTP-PEST at S39 was shown to down-
regulate PTP-PEST activity by decreasing its affinity for substrate through the 
meditation of PKC and PKA; however, phosphorylation at PTP-PEST (S435) 
does not have any influence over its activity (Garton and Tonks 1994; Nakamura 
et al., 2010). The substrates of PTP-PEST are predominantly cytoskeletal and 
focal adhesion proteins and include Src (Chellaiah et al., 2009), Pyk2 (Lyons et 
al., 2001; Davidson et al., 2010) and c-Abl (Cong et al., 2000).  Notably, it was 
shown that Y402, the major autophosphorylation site of Pyk2, as well as the 
activation loop tyrosine residues, Y579 and Y580, are regulated by PTP-PEST 
(Lyons et al., 2001), thus implicating PTP-PEST as important player in the 
mediation of Pyk2 actions.    
 
N-methyl D-aspartate receptor signaling  
The N-methyl D-aspartate receptor (NMDAR), a specific type of ionotropic 
glutamate receptor, has been intensively studied. It is widely expressed in the 
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CNS, shows specialized characteristics such as voltage-dependent block by 
magnesium, calcium permeability and slow deactivation kinetics, and plays a role 
in controlling synaptic plasticity and memory function (Cull-Candy et al., 2001). 
The NMDAR, comprised of NR1, NR2 and NR3 subunits which form the central 
conductance pathway, are tightly associated with various proteins that mediate 
NMDA signaling; together with its interacting partners (calmodulin kinase II 
(CaMKII), PKA and PKC, Src and Pyk2, scaffolding proteins and trafficking 
proteins, it forms the so-called NMDAR complex (Stephenson, 2006). Several 
tyrosine phosphorylation sites are located in NR2 (including NR2A and NR2B), 
but not in the NR1 subunit. Among these sites, Y1472 in the NR2B C-terminal 
cytoplasmic domain has been shown to be the primary substrate in NR2B that is 
targeted by Src kinase (Cheung and Gurd, 2001). 
 
Electrophysiological studies showed that NMDAR currents in neurons are 
regulated by the phosphorylation and dephosphorylation of tyrosines of various 
proteins; thus inhibiting endogenous PTP activity or introducing exogenous PTK 
into cells enhances NMDAR currents, and vice versa (Wang and Salter, 1994).  
Several SFK, especially Src, have been found to be endogenous up-regulators of 
NMDAR activity in a tyrosine phosphorylation-manner. For example, synaptic 
NMDAR-mediated currents have been reported to be up-regulated by Src kinase 
in cultured neurons and slices of hippocampus (Yu et al., 1997; Lu et al., 1998).  
In addition, there is evidence to suggest that the calcium-dependent activation of 
Src and Pyk2 may serve as a convergence point of multiple signaling pathways 
(e.g. GPCR, PTK and Ras pathways) that regulate divergent downstream 
mechanisms including NMDAR signaling which ultimately leads to LTP (Salter 
and Kalia, 2004).  
 
It has been well demonstrated that elevated GC suppress hippocampal synaptic 
potentiation (Smriga et al., 1996; Xu et al., 1998; Alfarez et al., 2002) by 
modulating NMDAR signaling (Kim et al., 1996; Wiegert et al., 2005); several of 
these studies have suggested mediation of these GC effects by classical nuclear 
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GR. Notably, the ability of CORT to modulate NMDAR function appear to vary 
according to neuronal type in the mouse hippocampus; thus, while the steroid 
rapidly influences NMDA-induced Ca2+ elevation in the CA1, but not in CA3 
region and dentate gyrus (Sato et al., 2004). Other studies have reported that 
CORT rapidly modulates NMDA currents through the mediation of the PKA 
signaling pathway (Liu et al., 2007). Lastly, CORT has been recently shown to 
rapidly enhance NMDA neurotoxicity by increasing intracellular Ca2+ levels and 
attenuating NR2A-ERK-mediated neuroprotective signaling in rat hippocampus 
(Xiao et al., 2010).   
 
Mitogen-activated protein kinase  
In mammals, the mitogen-activated protein kinases (MAPK), a family of 
serine/threonine protein kinases which have classically been studied as 
regulators of cell proliferation and differentiation (Seger and Kreb, 1995), include 
three members: extracellular signal-regulated kinase (ERK), c-jun N-terminal 
kinase (JNK), and p38 MAP kinase. The two ERK isoforms, p44 MAPK (ERK1) 
and p42 MAPK (ERK2), have been shown to ubiquitously express in the CNS 
and may mediate effects of growth factors or neurotransmitters on the dendritic 
cytoskeleton (Fiore et al., 1993). ERK 1/2, as the prototype of MAPK family, has 
been best studied for its intracellular signaling pathways which mediate the 
transmission of signals induced by various extracellular stimuli, such as cytokines, 
growth factors, neurotransmitters and hormones; thus, they transducer signals 
from the cell surface to cytoplasmic and nuclear effectors.  Classically, the ERK 
signaling pathway contains a three-step protein kinase activation cascade, 
including the MAPK kinase kinases, RAS and RAF which sequentially activate 
the MAPK kinase MEK, which in turn activates ERK. Activated ERK translocates 
into the nucleus where it directly or indirectly activates downstream transcription 
factors such as early growth response-1 (Egr-1), which was shown to be target of 
activated GR, and cAMP response element-binding (CREB) protein; the latter is 
strongly implicated in synaptic plasticity and learning among a large spectrum of 
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other functions necessary for survival (Rubinfeld and Seger 2005; Hardingham et 
al., 2001; Revest et al., 2005; Davis and Laroche, 2006).  
 
The important role of the MAPK family in rapid GC effects has been appreciated 
for years. GC have been reported to trigger rapid and non-genomic activation of 
the MAPK family members p38, JNK, and ERK in PC12 cells (Li et al., 2001; Qiu 
et al., 2001) and cultured hippocampal neurons (Qi et al., 2005; Xiao et al., 2005) 
via a putative membrane receptor through a PKC-dependent signaling 
mechanism.  GC were also shown to rapidly increase the frequency of mEPSC in 
mouse CA1 pyramidal neurons via membrane-located non-genomic MR involving 
MEK/ERK signaling pathways (Olijslagers et al., 2008). Interestingly, ERK is 
rapidly activated via a NMDAR-dependent pathway to induce synapse plasticity 
in rat hippocampus (Kaphzan et al., 2006).  
 
 
Rho family 
The Rho family GTPases are low-molecular weight guanine nucleotide-binding 
proteins, which generally function as binary molecular switches that cycle 
between an active GTP-bound and inactive guanosine diphosphate (GDP) -
bound state. Their activity can be positively influenced by guanine nucleotide 
exchange factors (GEF), GTPase activating proteins (GAP) and guanine 
nucleotide dissociation inhibitors (GDI) (Jaffe and Hall, 2005). Rho GTPases are 
regulated by direct phosphorylation or ubiquitination (Lang et al., 1996; Wang et 
al., 2003b), but the detailed mechanisms which may mediate these post-
translational modifications are not fully characterized. Currently, 22 Rho family 
members have been identified in the mammalian genome, the most studied 
members being Cdc42, Rac1 and RhoA (Aspenström et al., 2004).  These 
proteins regulate signaling pathways related to actin-dependent cellular 
processes, such as the assembly and organization of the actin cytoskeleton (Hall, 
1998; Etienne-Manneville and Hall, 2002) and regulate cellular functions that 
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include gene transcription, the cell cycle, cell morphogenesis and cell migration 
(Etienne-Manneville and Hall, 2002; Jaffe and Hall, 2005).  
 
Drebrin 
The filamentous actin (F-actin) is one of the major structural elements of dendritic 
spines and critical for the regulation of spine plasticity (Matus, 2000). Drebrin, a 
typical neuron-specific F-actin-binding protein, is abundantly expressed in 
dendritic spines, the postsynaptic elements that receive the majority of excitatory 
glutamatergic inputs in the CNS, and plays an important role in spine 
morphogenesis and morphology (Sekino et al., 2007). In developing hippocampal 
neurons, drebrin was shown to be involved not only in clustering of PSD-95 
(Takahashi et al., 2003), but also in activity-dependent synaptic targeting of 
NMDAR (Takahashi et al., 2006). Interestingly, drebrin levels were shown to be 
markedly decreased in the brains of patients with Alzheimer’s disease (Kojima 
and Shirao, 2007), in keeping with the view that Alzheimer’s disease reflects 
synaptic dysfunction (Roselli et al., 2011).  
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1.5. The hippocampus as a model to study the rapid actions of 
corticosteroids  
 
The adaptive response to stress needs not only the regulation of the HPA axis, 
but also the coordination of limbic system structures, including the amygdala, 
prefrontal cortex and hippocampus. The adaptations in these structures involve 
rapid mechanisms of synaptic plasticity. The hippocampus has proven an ideal 
structure in which to investigate molecular, signaling cascades and electro-
physiological aspects of how information is encoded, transmitted and stored in 
neuronal circuits to regulate behavior. In particular, the simple laminar structure 
of the hippocampus has facilitated the use of extracellular recording techniques 
to record synaptic events in vivo (Tsien et al., 1996); notably, the hippocampus 
has been extensively studied in the context of long-term potentiation (LTP) and 
long-term depression (LTD), which have been strongly implicated to correlates 
with learning and memory (Bliss and Collingridge 1993). While most electro-
physiological experiments are carried out on hippocampal slices, methods are 
well established for preparing primary cultures of hippocampal neurons from both 
embryonic and postnatal rodents.  
 
As shown in Figure 8, the hippocampus proper comprises pyramidal neurons of 
the Cornus Ammon, subdivided into 3 layers (CA3, CA2 and CA1) pyramidal cell 
regions), granule neurons of the dentate gyrus, and basket and interneurons of 
the hilus. The hippocampus proper1 is innervated by the entorhinal cortex via the 
perforant pathway that mainly terminates on granule cells in the dentate gyrus 
but also distal dendrites of CA3 pyramidal cells which further project to the CA1 
region via Schaffer collaterals.  
 
                                                 
1 Although most researchers use the term hippocampus to refer to the hippocampus proper, the 
neuroanatomical literature strictly reserves this term to refer to the inter-connected entorhinal 
cortex, the hippocampus proper and the s subiculum (main output of the hippocampus); 
alternatively, this collection of structures may be referred to as the hippocampal formation. 
However, in this work, the common usage of the term hippocampus (instead of hippocampus 
proper) will be applied for convenience.  
INTRODUCTION 
 - 35 -
 
 
 
 
Figure 8. Diagram of the anatomy of the rat hippocampus.  This figure is showing the location 
and organization of the hippocampus. Three coronal sections through the left hippocampus are 
shown at the bottom right of the figure, with their approximate anteroposterior coordinate relative 
to bregma. CA1, CA2, CA3: cornu ammonis fields 1–3; DG: dentate gyrus; EC: entorhinal cortex; 
f: fornix; s: septal pole of the hippocampus; S: subiculum; t: temporal pole of the hippocampus. 
(Adapted from Cheung and Cardinal, 2005) 
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The hippocampus is a major target of corticosteroids. Of all brain regions, it is 
endowed with the greatest density of classical (nuclear) MR and GR, and 
corticosteroids cause both reversible and irreversible changes in hippocampal 
structure and hippocampus-related memory (Sousa and Almeida, 2002; Joëls 
2008). There is a large literature that describes the actions of GC on synaptic 
plasticity in the hippocampus, although the mechanisms remain largely unknown. 
For example, low levels of corticosterone alter synaptic plasticity in the CA1 
subfield and dentate gyrus (Alfarez et al., 2003); such effects have also been 
seen after chronic stress and can be reversed with brief treatment with the GR 
antagonist, RU38486 (mifepristone) (Krugers et al., 2006). In another study, 
acute stress was found to increase voltage-dependent calcium currents in rat 
hippocampus through the mediation of GR (Karst and Joëls., 2007). In contrast, 
the rapid regulation of NMDA-induced Ca2+ influx in hippocampal slices by CORT 
was ascribed to mediation by putative membrane receptors, the nature of which 
was not specified (Sato et al., 2004). CORT has also been reported to enhance 
the electrophysiological activity of hippocampal CA1 neurons and to reduce 
paired-pulse facilitation via a membrane MR-dependent and transcription-
independent manner, suggesting a hormone-dependent enhancement of 
glutamate-release probability (Karst et al., 2005). On the other hand, acute GC 
stimulation in hippocampal slices was shown to rapidly enhance LTP of Schaffer 
collateral inputs to CA1 pyramidal neurons in an MR- and GR-independent 
fashion (Wiegert et al., 2006).  
 
Although the transcriptional actions of GC have been proved to regulate long-
term hippocampal neurons responses of afferent inputs, the rapid action of GC in 
the hippocampus, which may be mediated though putative membrane receptors, 
provides possible mechanisms for the acute effects of GC in various cellular 
functions.  
 
Generally, much evidence indicates that corticosteroids, especially GC, are 
tightly associated with hippocampal cognitive impairment, cellular changes and 
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neuronal survival. Hippocampus, as the main target of stress-induced hormones, 
has been found to relate to many diseases and disorders, such as depression, 
amnesia, epilepsy, schizophrenia and Alzheimer's disease (de Kloet et al., 2005; 
Sotiropoulos et al., 2008). To investigate the mechanisms, either genomic or non-
genomic, of GC-induced modulation on hippocampal functions provides 
approaches to understand how stress affects the brain and cognition.   
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2. AIMS OF THIS STUDY 
Much emerging evidence indicates that corticosterone (CORT) exerts rapid non-
genomic effects in multiple tissues and cell types, including the hippocampus. 
The role of classical (nuclear) corticosteroid receptors and putative membrane 
receptors in the mediation of rapid CORT signaling are controversial. Although 
some authors suggest the involvement of G-proteins, PTK, NMDAR and MAPK in 
the signaling pathways of the non-genomic effects of CORT, the detailed 
mechanisms that potentially regulate these cascades in neuronal cells remain 
largely unknown at the present time. Understanding the rapid signaling pathways 
induced by CORT are important because this hormone produces fast changes in 
physiology or behavior. In the present study, experiments were undertaken to 
investigate the following specific questions: 
 
• Is rapid CORT-induced signaling initiated at a membrane receptor in 
hippocampal neuronal cells? What are the roles of classical corticosteroids 
receptors (MR and GR) in these signaling cascades? 
 
• How is the secondary signal transduction of CORT regulated in the 
cytoplasm? What might be the interactions between various intracellular 
mediators (G-protein, PTK and MAPK) in the final responses to rapid 
CORT singling?  
 
• How does rapid CORT-induced signaling influence cellular functions such 
as gene transcription, cell morphogenesis and synapse function? 
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3. MATERIALS AND METHODS 
 
3.1. Primary hippocampus neuronal culture 
Primary neurons from the rat hippocampus were cultured according to a method 
described by (Roselli et al., 2005), with slight modifications. Cultures were 
prepared from Wistar rat pups aged 4-5 days; pups were born to mothers 
obtained from Charles River (Sulzfeld Germany) on gestation day 18-19, and 
held under standard laboratory conditions. All animal experiments were 
conducted in accordance with German laws on the use of animals in research 
and were approved by the local ethics committees. 
On the day of culture, pups were sacrificed by rapid decapitation and the brains 
quickly taken out and placed in a 5 cm Petri dish containing ice-cold dissection 
solution (Solution I)2.  
Hippocampi from both hemispheres were dissected out, and transferred to a 
second Petri dish containing fresh, ice-cold Solution I. After dissection of the last 
hippocampus, hippocampal explants were sliced (250 µm) using a McIlwain 
tissue chopper (Camden Instruments, Leics, UK). Slices (with minimal Solution I) 
were  placed in trypsin digestion solution (Solution II)3 in a 50 mL tube and 
incubated in a shaking water bath (37 °C, 200 rpm) for 10 minutes. Thereafter, 
                                                 
2 Solution I, Dissection solution  
B27 (GIBCO), 50X 1 mL
NeuroBasal A (GIBCO)   49 mL
 
3 Solution II, Trypsin digestion solution  Final concentration 
Trypsin (GIBCO), 2.5%      0.1 mL 0.05 % 
BSA (Sigma), 7.5%                                      0.2 mL 3 mg/mL 
DNase (Worthington), 2000U/ml 0.125 mL 50 U/mL 
EBSS 4.575 mL  
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trypsin inhibitor solution (Solution III) 4 , was added and slices were gently 
triturated using a 10 mL round-edged, plastic pipette (Sarstedt, Ulm, DE). 
Following brief centrifugation (70 g, 30 seconds), the pellet was re-suspended in 
Solution III and filtered through a 30 µm nylon mesh (VWR, München, DE). 
Dissociated cells (in filtrate) were then centrifuged (200 g, 6 minutes) and the 
pellet was resuspended in 3 mL Solution I to which 0.125mL DNase (2000U/mL; 
GIBCO) and 0.3 mL BSA (7.5%; Sigma) was added. Dead cells and cell debris 
were subsequently excluded using a density gradient (Solution IV) 5 . After 
centrifugation (70 g, 6 minutes), the resulting pellet was resuspended gently in 
pre-warmed Growing Medium6. An aliquot of the cell suspension was used to 
estimate the number of cells using a Neubauer hemocytometer (Strober, 2001). 
This estimate was used to dilute the cell suspension in Growing Medium to give a 
cell density of, respectively 300 cells/mm2 or 450 cells/mm2 when plated onto pre-
coated glass coverslips (0.13-0.17 mm,12X12 mm Marienfeld, DE) or 6-well 
plates (NUNC).  
 
 
Glass coverslips were pre-cleaned by washing in chromosulfuric acid (Merck, 
Darmstadt, DE) for 2 hours, sequential washing in tap and distilled water to 
remove all traces of acid, boiling in absolute ethanol for 1 h, and overnight drying 
                                                 
4 Solution III, Trypsin inhibitor solution   Final concentration 
Soy bean trypsin inhibitor (Sigma), 4mg/ml 1.5 mL 0.4 mg/mL 
BSA (Sigma), 7.5%        0.6 mL 3 mg/mL 
FCS (GIBICO)                                                            0.3 mL  
B27 (GIBCO), 50X 1 mL 1 X 
NeuroBasal A (GIBCO)   12.3 mL  
 
5 Solution IV, Density gradient solution  
BSA (Sigma) 7.5%                                      3 mL
Solution I                                                     2 mL
 
6 Growing Medium  Final concentration 
B27 (GIBCO) , 50X      1 mL 1 X 
GlutamaxI (GIBCO), 200 mM 0.25 mL 1 mM 
bFGF (GIBCO), 4 μg/ml 0.125 mL 10 ng/mL 
Kanamycin (GIBCO), 100X                            0.5 mL 1 X 
NeuroBasal A (GIBCO)   48.25 mL  
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at 200 °C; prior to plating, coverslips were placed individually in the wells of 6-well 
plates (NUNC). Coverslips and 6-well plates were coated with gelatine7 (2 hours, 
room temperature) before coating (at least 2 hours, room temperature) with poly-
D-lysine (PDL; MW: 70,000 – 150,000; Sigma)8. Subsequently, the PDL was 
aspirated, and coverslips and plates were washed thoroughly (3 times) with 
sterile dH2O. Coverslips and plates were then stored in a incubator (37 °C; 95% 
relative humidity) until used.  
 
Cells were plated in 1 mL Growing Medium and allowed to attach for 30 minutes 
after which a further 1 mL of Growing Medium was added to each well. After 
plating, cells were grown in 2 mL Growing Medium; every 3 days, 1 mL of 
medium was aspirated off gently and replaced by 1 mL of fresh (37 °C). Cells 
were maintained for 10-13 days before treatments were applied.  
 
Characterization of the cultures by immunocytochemistry revealed the presence 
of cells with the following phenotypes: mature, MAP-2- (microtubule-associated 
protein, a dendritic marker of mature neurons) positive cells and NeuN- (neuronal 
nucleus, a vertebrate neuron-specific nuclear protein) positive cells; these cells 
accounted for around 45% and 55% of the cultures, respectively (based on 
counting of all cells, labeled with Hoechst 33342, a marker of DNA) at 12 days in 
vitro (Fig 3.1).   
                                                 
7 Gelatin solution, 0.08%  
Gelatin (Sigma) 0.04 g
Borate Buffer (0.024M, pH 8.2-8.4) 50 mL 
Sterilize using 0.2 μm filter 
 
8 Poly-D-Lysine (PDL) solution,  0.031 mg/mL  
PDL (Sigma), 1mg/mL 1 mL 
Borate Buffer (0.024M), sterilized 32.2 mL 
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3.2. Pharmacological treatments 
Before any drug application, cells were “starved” to remove the potentially 
interfering effects of growth and other factors in the Growing Medium; this was 
achieved by placing cells in unsupplemented NeuroBasal A (GIBCO) for 3 hours. 
Drugs were applied to cells for 30 minutes unless specifically stated otherwise. 
Appropriate vehicles (and controls) were used for each drug (see Table 3.1); 
these were deimethylsulfoxide (DMSO), 40% cyclodextrin or, in certain cases, 
100% ethanol; vehicle concentrations were kept to a maximum of 0.1% (final 
concentration) in order to avoid confounding effects.  
 
3.3. Immunocytochemistry 
Immunocytochemistry was used to phenotypically characterize the cultures, but 
also to detect the localization, distribution and expression level of specific 
proteins in cultured cells. After treatments, cells on coverslips were briefly 
washed with pre-warmed (37 °C) phospho-buffered saline (PBS)9 and fixed with 
ice-cold 4% paraformaldehyde10 for 10 minutes at room temperature. Following 3 
temperature to reduce non-specific binding of primary antibodies; the BSA was 
                                                 
9 Phosphate buffered saline (PBS)  Final concentration 
NaCl (Roth) 8.0 g 137 mM 
KCl (Merck) 0.2 g 2.7 mM 
Na2HPO4·7H2O (Roth) 2.16 g 8.0 mM 
KH2PO4 (Merck) 0.2 g 1.5 mM 
dH2O Up to 1 L  
Adjust pH to 7.4, sterilize through 0.2 μm filter 
10 4% Paraformaldehyde (PFA)  Final concentration 
Na2HPO4·7H2O  (Roth) 2.16 g 0.08 M 
NaH2PO4 (Roth) 0.24 g 0.02 M 
Paraformaldehyde (SIGMA) 4 g 4% 
dH2O Up to 100 mL  
Adjust pH to 7.4, Heat at 56°C to dissolve. Prepare freshly before use. 
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washes (5 minutes each), cells incubated in 3% BSA for 1 hour at room usually 
diluted in PBS or in PBST11 when cell surface antigens were to be visualized; in 
the latter case, this permeabilization step preceded the incubation with BSA (see 
above). Cells were subsequently incubated with specific primary antibodies (see 
Table 3.2.) diluted in blocking buffer (3% BSA in PBS) at 4 °C overnight. After 
extensive washing with PBS at room temperature (3 times, 30 minutes each), 
cells were incubated with appropriate fluorescent-tagged secondary antibodies 
(see Table 3.3) diluted in PBST (again, those for cell surface protein staining 
were diluted in PBS) for1 hour at room temperature. Specimens were then 
washed (PBS, 3 times, 30 minutes each) and incubated with the DNA-
intercalating dye Hoechst 33342 (Invitrogen; diluted in PBST for 10 min at room 
temperature, to visualize cell nuclei. After extensive washing with PBS at room 
temperature, cells were mounted onto glass slides with anti-fade mounting 
medium12, dried overnight and then examined by microscopy. 
 
 
                                                 
11 Phosphate buffered saline- Triton (PBST)  Final concentration 
Triton-X100 (Roth) 300 μL 0.3 % 
PBS Up to 100 mL  
The concentration of Triton-X100 was further optimized when using certain antibodies.  
 
12 Mounting Medium  
Glycerol (Sigma) 6 g
Mowiol 4-88 (Calbiochem) 2.4 g
dH2O 6 mL
Tris buffer (0.2 M), pH 8.5 12 mL
Store at -20°C. 
 
MATERIALS AND METHODS 
 - 45 -
Table 3.1 Drugs used in this study 
 
Drugs Description Dose Vehicle Source 
2-Aminoethyl diphenylborinate, 2-APB Modulator of intracellular IP3-induced calcium release 100 µM EtOH Sigma, Deisenhofen, DE
AG1478 Selective inhibitor of EGFR 10 µM DMSO Sigma
API-2 Selective inhibitor of Akt/PKB  30 µM DMSO Tocris, Bristol, UK
BAPTA-AM Selective chelator of intracellular Ca2+  13 µM H2O Sigma
CaMKII inhibitor (CI) Inhibitor of Ca2+/calmodulin (CaMKII)  10 µM H2O Calbiochem, La Jolla, CA
Corticosterone-BSA, (CORT-BSA) Cell-impermeable conjugate of BSA and CORT 100 nM H2O ABiox, Newberg, OR 
2-hydroxypropyl-β-cyclodextrin   
corticosterone 
Water-soluble CORT (CORT:HBC) 10 nM H2O Sigma
CORT 182097 Selective antagonist for GR 100 nM EtOH Corcept Therapeutics, CA
Cycloheximide, CHX Protein synthesis inhibitor 10 µM DMSO Sigma
Eplerenone  Selective MR antagonist (<AR, PR and ER) 100 nM DMSO Tocris
Forskolin Cell-permeable activator of adenylate cyclase 10 µM DMSO Tocris
G-15 Selective GPR30 receptor antagonist 1 µM DMSO Tocris
GDP-β-S Non-hydrolysable GDP analog 100 µM H2O Sigma
Gö 6983 PKC inhibitor 5 µM DMSO Sigma
TDZD-8 Selective inhibitor of GSK-3β 10 µM DMSO Merck, Darmstadt, DE
GW 5074 Selective c-Raf1 kinase inhibitor 1 µM DMSO Tocris
H-89 Selective inhibitor of PKA 1 µM DMSO Calbiochem
J2700 GR antagonist  100 nM DMSO Gift, Jenpahram, Jena/DE 
JAK inhibitor Potent inhibitor of Janus tyrosine kinases.  1 µM DMSO Calbiochem
K252a Specific and potent inhibitor of Trk  1 µM DMSO Sigma
MK801 Selective NMDAR antagonist.  10 µM H2O Tocris
NMDA Prototypic NMDAR agonist 100 nM H2O Tocris
PD 98059 Specific inhibitor of MAPK  25 µM DMSO Tocris
Pertussis toxin (PTX) Gi- and Go- protein inhibitor                                             500 mg/L H2O List Biologicals,  CA
PF431396 Potent pyrimidine-based Pyk2 inhibitor 3 µM DMSO Symansis, Timaru, NZ
PP2 Selective inhibitor of the Src family  1 µM DMSO Calbiochem
PP3 Negative control for the PP2  1 µM DMSO Calbiochem
RU 28318 Selective antagonist for MR 100 nM H2O Tocris
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Drugs Description Dose Vehicle Source 
RU 38486 PR and GR antagonist 100 nM CyD Sigma
Spironolactone, SPIRO Competitive MR and AR antagonist 100 nM DMSO Tocris
STI-571 Selective inhibitor of c-Abl and PDGFR  1 µM DMSO Cayman,  Ann Arbor, MI
SU6656 Potent Src family kinase inhibitor 1 µM DMSO Calbiochem
Syk inhibitor Potent Spleen tyrosine kinase inhibitor  1 µM DMSO Calbiochem
Thapsigargin Inhibitor of endoplasmic reticulum Ca2+-ATPases 1 µM DMSO Tocris
U 73122 PLC inhibitor 5 µM DMSO Tocris
U0126 Selective inhibitor of MAPK kinase. 10 µM DMSO Tocris
Verapamil Inhibitor of L-type Ca2+ channels  50 µM EtOH Sigma
W7 Calmodulin antagonist 50 µM DMSO Tocris
Wortmannin Selective inhibitor of PI3K 4 µM DMSO Tocris
DMSO: Dimethyl sulfoxide (SIGMA); CyD: 40% Cyclodextrin (SIGMA); EtOH: 100% Ethanol 
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Table 3.2. Primary Antibodies used for 
Immunocytochemistry and/or Immunoblotting 
Antibody Host WB ICC Source 
Actin  Mouse 1:5000 Millipore, Billerica, MA
c-Abl Phospho-Tyr 412  Rabbit 1:1000 Novus, Littleton, CO
CaMKII, Phospho-Thr286  Rabbit 1:1000 Cell Signalling, Danvers, MA
CREB Phospho-Ser133 Rabbit 1:1000 Cell Signalling
Drebrin Rabbit 1:5000 IBL, Hamburg, DE
EGR 1 Rabbit 1:1000 Cell Signalling
JNK Phospho  Rabbit 1:1000 Cell Signalling
Map2  Rabbit 1:200 Millipore
Map2a/b  Mouse 1:500 Sigma, Deisenhofen, DE
Neuronal Nuclei (NeuN),   Mouse 1:200 Chemicon
NMDA-NR2B (pTyr1472) Rabbit 1:1000 Cell Signalling
NMDA-R1  Mouse 1:100 BD Biosciences, San Jose, CA 
NR2B glutatmate rec  Rabbit 1:200 Sigma
p38 Phospho-spec  Rabbit 1:1000 Cell Signalling
p44/42, Erk 1/2 Rabbit 1:2000 Cell Signalling
p44/42, Erk 1/2 Phospho Rabbit 1:1000 Cell Signalling
PSD-95  Mouse 1:400 Acris, Herford, DE
PTP-PEST Phospho-Ser39 Rabbit 1:1000 Dr. K. Mashima, Rikkyo University, JP
P-Tyr-100, Phospho-Tyrosine  Mouse 1:1000 Cell Signalling
Pyk2  Rabbit 1:2000 Cell Signalling
Pyk2 Phospho-Tyr402  Rabbit 1:200 Biosource
Pyk2 Phospho-Tyr402  Rabbit 1:1000 Invitrogen, Darmstadt, DE
Pyk2 Phospho-Tyr579  Rabbit 1:1000 Invitrogen
Pyk2 Phospho-Tyr580  Rabbit 1:1000 Invitrogen
Pyk2 Phospho-Tyr881  Rabbit 1:1000 Invitrogen
Src antibody Rabbit 1:2000 Cell Signaling
Src Phospho-Tyr416 Rabbit 1:1000 Cell Signalling
Src Phospho-Tyr527 Rabbit 1:1000 Cell Signalling
Synapsin 1 Rabbit 1:750 Sigma
 
 
Table 3.3. Secondary antibodies used in ummunocytochemistry 
Antibody (primary) target Dilution Source 
HRP-conjugated anti mouse 1:2000 Jackson Labs, Bar Harbor, ME 
HRP-conjugated anti rabbit  1:2000 Jackson Labs 
Alexa Fluor 488 anti mouse  1:400 Molecular Probes/Invitrogen 
Alexa Fluor 594 anti mouse  1:400 Molecular Probes 
Alexa Fluor 488 anti rabbit  1:400 Molecular Probes 
Alexa Fluor 594 anti rabbit  1:400 Molecular Probes 
 
MATERIALS AND METHODS 
 - 48 -
3.4 Confocal imaging and deconvolution analysis 
Fluorescent imaging of immunohistochemical staining of cultured cells was 
performed on an Olympus FV-1000 laser scanning microscope with Fluoview 
software (Olympus, Tokyo, Japan). Images were obtained from 5-7 optical fields 
chosen across individual coverslips and slices using a Kalman filter and 
sequential scanning mode; standard (saved) settings for laser power; 
photomultiplier gain and offset were used. In the case of double or triple labeling, 
each channel was recorded consecutively to avoid cross-excitation and emission. 
Z-stack images were obtained from each optical field and each z-stack image 
was ultimately collapsed into a single plane to create a 2 dimensional image. 
Usually, 7-9 z-stack images were taken for a single cell at a resolution of 1024 x 
1024 pixels with a 40× water-immersion objective (NA 1.15, Olympus) or a 60 x 
water-immersion objective (NA 1.20, Olympus).  
 
NIH ImageJ (Rasband, 1997–2011) software was used to process and analyze 
the captured images. Images were imported into ImageJ software, converted to 
8-bit grayscale; unified thresholds were used for all images. When identifying 
colocalized puncta, the ‘Co-localization Highlighter’ plugin was used and analysis 
was done with the ‘Analyze Particle’ module of the ImageJ program. 
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3.5 Protein sample preparation 
Cells from 6-well plates were briefly washed with ice-cold PBS, followed by 150 
µL ice-cold Lysis Buffer13. After gently shaking, the cells were left on ice with 
Lysis Buffer for 5 minutes before being harvested with a commercial plastic cell 
scraper. Scraped cells in buffer were then quickly transferred into pre-chilled 1.5 
mL Eppendorf tubes and briefly sonicated (Branson). Finally, lysates were 
centrifuged at 4 °C, (13,200 rpm) for 10 minutes and supernatants were stored at 
-80 °C for further analysis. 
 
Aliquots of the cell lysates were used to determine protein concentrations in the 
lysates using the Lowry method (Lowry et al., 1951). The reagents for the assay 
are provided in the footnote14. For the assay, samples were diluted (e.g. 1:50) in 
150 µL deionized (DI) H2O. A 1 mg/mL BSA (Sigma) solution was used to provide 
                                                 
13 Lysis Buffer, 1 mL  Final concentration
Tris-Cl (ROTH), 1 M, pH 7.5 50 µL 50 mM
NaCl (ROTH), 5 M 30 µL 150 mM
EDTA (SIGMA), 0.5 M 2 µL 1 mM
MgCl2 (SIGMA), 1M 5 µL 5 mM
Nonidet P40 (Fluka), 10% 100 µL 1%
Sodium deoxycholate, (SIGMA), 5% 100 µL 0.5%
Protease Inhibitor (Roche), 50x 20 µL 1x
Phosphatase Inhibitor 1, (SIGMA) 10 µL
Phosphatase Inhibitor 2, (SIGMA) 10 µL
Deionized (DI) H2O 673 µL
Prepare fresh on ice before use.  
 
14 Lowry solution A  
Na2CO3 (SIGMA) 2 g
0.1 M NaOH (SIGMA) Up to 100 mL
Lowry solution B  
KNaC4H4O6 (SIGMA) 2 g
DI H2O Up to 100 mL
Lowry solution C  
CuSO4 (SIGMA) 1 g
DI H2O Up to 100 mL
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linear concentrations (also in 150 µL DI H2O) for use as standards.  The assay 
was conducted by adding 750 µL of Lowry reagent to standards and samples, 
mixing and incubation for 15 minutes at room temperature. Thereafter, 75 µL of 
Folin-Ciocalteus Phenol Reagent (Merck; 1:2 dilution in DI H2O) and the mixture 
was allowed to stand for 1 hour at room temperature. Finally, the absorbance of 
standards and samples were measured at 750 nm with a Synergy-HT (Bio-Tek) 
plate reader.  
 
 
3.6 Immunoblotting 
3.6.1. SDS-PAGE  
The first and critical step in immunoblotting is separating out proteins according 
to size using SDS-polyacrylaminde gel electrophoresis (SDS-PAGE). To this end, 
appropriate volumes of each sample were diluted 1:1 in 1 x Laemmli Buffer15 to a 
volume of 30 µL. Samples were then boiled at 95 ºC for 10 min to denature and 
linearise the proteins. After boiling, samples were briefly mixed and centrifuged at 
13,200 rpm for 30 seconds, after which 50 µg protein was carefully loaded onto 
8% or 10 % (according to target protein size) Tris-Cl polyacrylamide gels (PAGE 
                                                 
15 Laemmli Buffer,6x  
Stacking Gel Buffer, Stock 3.5 mL
Glycerol (SIGMA) 1.5 mL
Dithiothreitol (DTT, SIGMA)  0.465 g
SDS (SIGMA) 0.5 g
Bromphenol blue   0.6 mg
DI H2O Up to 5 mL
Store at –20°C 
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gels, see Table 3.4), along with a pre-stained protein molecular weight marker 
(Fermentas, St. Leon-Rot, DE). 
Table 3.4 The preparation of SDS-PAGE Gel. 
Separating Gel Mix,.1.5 mm thickness gel 8 % gel 10 % gel 
Rotiphorese Gel 30, (Roth), 30%  2,1 mL 2,7 mL 
16Separating Gel Buffer Stock 2 mL 2 mL 
DI H2O 3,9 mL 3,3 mL 
1710% Ammonium Persulfate (APS)   40 µL   40 µL 
Tetramethylethylenediamine (TEMED, SIGMA)      6 µL     6 µL 
18Stacking Gel Mix,.1.5 mm thickness gel  
stacking gel buffer 3 mL 
10% APS   20 µL 
TEMED      3 µL 
 
The gels were run in a Bio-Rad electrophoresis system (Bio-Rad, Hercules, USA) 
filled with Electrophoresis Chamber Buffer19 (both inner and outer chambers).  A 
constant voltage of 75 V was applied to the gel until the tracking dye migrated 
towards the bottom of the gel. Next, the gel was briefly washed in ice-cold 
                                                 
16Separating Gel Buffer, Stock  
Tris-Cl (ROTH) 91 g
SDS (SIGMA) 2 g
DI H2O Up to 500 mL
 
17 Ammonium Persulfate (APS), 10%  
Ammonium Persulfate (SIGMA) 10 g
DI H2O Up to 100 mL
 
18 Stacking Gel Buffer, Mix  
Rotiphorese Gel 30, (Roth), 30% 13.3 mL
Stacking Gel Buffer, stock (see below) 25 mL
DI H2O Up to 100 mL
 
Stacking Gel Buffer, Stock  
Tris-Cl (ROTH) 6.05 g
SDS (SIGMA) 0.4 g
DI H2O Up to 100 mL
 
19 Electrophoresis Chamber Buffer  
Tris-Cl (ROTH) 3 g
Glycine (ROTH) 14.4 g
SDS (SIGMA) 1 g
DI H2O Up to 1 L
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Transfer Buffer before transfer of electrophoresed proteins to nitrocellulose 
membranes (Bio-Rad, Hercules, USA) in a Bio-Rad blotting apparatus (18 V for 
45 minutes, 60 minutes or 90 minutes, depending on target protein size), using 
Transfer Buffer20. Successful transfer was confirmed by Ponceau staining of the 
membrane. The membrane was then quickly rinsed with DI H2O twice and 
TBST21 once (5 minutes each) and incubated, with shaking, in Blocking Buffer22 
for 60 minutes at room temperature. After briefly washing 3 times with DI H2O, 
the membrane was incubated with primary antibody in 1% to 5% BSA in TBST or 
Blocking Buffer (optimized for each primary antibody) for 2 to 4 hours at room 
temperature or overnight at 4 ºC. Antibodies were affinity-purified and used at 
1000 to 5000-fold dilutions, as specified in Table 3.2. Unbound primary 
antibodies were removed by 3 X 10 minute washes in TBST. The membranes 
were then incubated with respective secondary antibodies conjugated to 
horseradish peroxidase (HRP, GE Healthcare, Freiburg) at room temperature for 
1 hour. The dilution of secondary antibodies was 1:2000 in Blocking Buffer in 
                                                 
20 Transfer Buffer  
Tris-Cl (ROTH) 3 g
Glycine (ROTH) 14.4 g
20% SDS (SIGMA) 2 mL
Methanol   100 mL
DI H2O Up to 1 L
Store at 4°C  
 
21 Tris-buffered saline-Tween (TBS-T)  
Tris-Cl (ROTH) 12.1 g
NaCl (ROTH) 17.6 g
Tween-20  (ROTH)  20 mL
DI H2O Up to 2 L
Adjust pH to 8.0. 
 
22 Blocking Buffer, 5%  
No-fat Milk Powder (Roth) 5 g
TBST Up to 100 mL
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most cases, but this was sometimes adjusted for individual primary antibodies. 
After further washing (3 times, 7 minutes) in TBST to remove unbound secondary 
antibodies, proteins were visualized using electrochemiluminescence (ECL; 
Roche, Mannheim, DE), according to the protocol from manufacturer. 
Membranes were then exposed to blue-light sensitive X-ray film (λmax = 428 nm; 
GE Healthcare) which were subsequently processed using Kodak developer and 
fixer (both from Sigma) according to the manufacturer's protocol.  
 
3.6.2 Semi-quantitative analysis of Immunoblots 
Subsequently, protein bands revealed on film (from at least 3 identical but 
independent experiments) were scanned with an EPSON scanner (fixed 
brightness/contrast settings) and analyzed using TINA software (Raytest, 
Straubenhardt, Germany). A fixed rectangular region of interest (ROI) was used 
to measure all bands and the optical density within each ROI was measured after 
background density was subtracted. All data were entered into Microsoft Excel 
files and subjected to further analysis.  
 
3.7 G-protein linked immunosorbent assay (GLISA) test 
3.7.1 Assay Principle  
G-LISA is a technique based on Enzyme-linked immunosorbent assay (ELISA) 
that allows efficient measurement of the activation of small GTPase, such as 
members of the Rho family, in cell or tissue samples. The basic steps of assay 
are shown in Fig 3.2.  
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Fig 3.2 A basic schematic of the steps involved in the G-LISA (Cytoskeleton Inc., Denver, 
CO, USA).  
 
 
 
Briefly, a 96-well plate covalently coated with a Rho-GTP-binding protein is used. 
Active GTP-bound Rho in cell lysates binds to the coated wells and inactive 
GDP-bound Rho is removed by washing steps. The bound active RhoA is then 
detected with a RhoA specific antibody and chemiluminescence. The degree of 
RhoA activation can be estimated by comparing readings from activated versus 
non-activated cell lysates (in these studies, using the culture ‘starvation’ protocol 
described in Section 3.1.). 
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3.7.2 Assay Protocol 
 G-LISA assay kits for assessment of RhoA activation were purchased from 
(Cytoskeleton Inc., Denver, CO) and used according, with slight optimization, to 
the manufacturer's protocol with optimization. Cells were washed once with ice 
cold PBS and harvested (see Section 3.5) with lysis buffer provided by the 
manufacturer. Lysates (drug-treated and control) were applied to the assay plates 
at a final concentration of 0.5 mg/mL, on ice. The plate was then placed on a cold 
orbital microplate shaker at 4 °C, 400 rpm for 30 minutes. After washing twice 
with Washing Buffer (provided in kit), each well was incubated with Antigen 
Presenting Buffer (provided in kit) at room temperature for 2 minutes after which 
the solution was removed and the plate washed 3 times with Washing Buffer. 
Next, anti-RhoA primary antibody (provided in the assay kit; 1:500) was added to 
each well, and the plate was incubated on a microplate shaker at room 
temperature (400 rpm, 45 minutes). After three washes, secondary HRP-labeled 
antibody (provided in kit; 1:500) was added to each well, and the plate was again 
incubated (microplate shaker, room temperature, 400 rpm, 45 minutes). 
Following removal of the secondary antibody and 3 washes, HRP detection 
reagent (provided in kit) was added and luminescence signal was detected within 
5 minutes, using a Bio-Tek Synergy HT microplate reader (gain setting fixed at 
100, integration time at 0.1 second; filters optimized to 590/30 to obtain 
reasonable relative luminescence units (RLU) that, in positive controls were 6-9 
fold higher than background). Data were transferred to Microsoft Excel 
worksheets and subjected to further analysis.  
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3.8 Statistics 
All immunoblotting data are depicted as mean ± standard deviation (SD) from 3-5 
independent experiments. Immunofluorescence data derive from evaluation of a 
minimum of 600 synapses (N) in each of 8-10 neurons (n). Data were analyzed 
for statistical significance using ANOVA and appropriate post hoc tests (Student-
Keuls or Kruskal-Wallis multiple comparison procedures, as appropriate) where p 
< 0.05 was set as the minimum level of significance. The SigmaStat software 
package (Systat Software GmbH, Erkrath, DE) was used for the statistical 
analysis.   
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4. RESULTS 
 
4.1 Primary hippocampal cultures as a valid model for studying 
the fast actions of CORT  
Previous studies describing the the rapid and non-genomic actions of CORT 
were done in a rat phaeochromocytoma cell line (PC12). They showed that 
CORT rapidly induces the activation of MAPK family signaling cascades (Li et al., 
2001; Qiu et al., 2001). In a later study, Qi et al. (2005) showed that CORT also 
triggered MAPK activation in neuronal cultures derived from the embryonic rat 
hippocampus. It is now known that the ERK/MAPK signaling cascade is regulated 
through numerous signal transduction regulators, including such as GPCR, PTK 
and ion channels and that the consequences of this activation include alterations 
in cellular excitability and the activation of transcription factors (and subsequently 
changes in gene expression) which, together, serve to induce synaptic plasticity, 
a phenomenon important for memory formation (Sweatt, 2004) as well as the 
expression of other behaviors. In the present work, a first step was to reproduce 
the earlier reports on CORT-induced activation of MAPK in primary hippocampal 
neurons obtained from postnatal rats.    
 
Given that the Growing Medium used for culturing primary hippocampal neurons 
contains various hormones and growth factors (see 3.2.1 for recipe) which could 
potentially activate the MAPK cascade, protocols had to be optimized to test 
whether “starvation” would overcome this potential confound. Experiments were 
thus designed in which cells were transiently deprived of Growing Medium and 
were instead maintained in NeuroBasal A medium (free from supplements as well 
as phenol red – an activator of estrogen receptors which are also known to 
potently activate the MAPK pathway - and glutamine). Results in Fig 4.1A show a 
time-course study from which a starvation period of 3 hours was determined to be 
sufficient so as to suppress endogenous expression of one MAPK, extracellular 
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Fig. 4.1: A. Deprivation of primary hippocampal neuronal cultures cells of Growing Medium 
(“starvation”) and replacement with supplement-free NeuroBasal A medium for 3 h suppresses 
endogenous activation of ERK 1/2. B. Treatment of cultures with DMSO, 40% cyclodextrin (CyD) 
and 100% ethanol (EtOH) (all at final concentrations of 0.1%) did not interfere with ERK 1/2 activity. 
Compared to untreated cells (CON), no significant changes of phosphorylated ERK 1/2 were 
observed. Levels of total ERK 1/2 and activated (phosphorylated) ERK 1/2 were determined by 
immuno- blotting. Total ERK 1/2 levels were not altered under any of the conditions tested.  
The immunoblot images shown are representative of at least 3 independent experiments. ** 
indicates p < 0.001 vs. untreated (CON) cells. 
signaling kinase 1/2 (ERK1/2), under basal (drug-free) conditions. Moreover, this 
paradigm did not cause any significant alteration in the morphology (signs of 
apoptosis) of the cells, determined by Hoechst staining and microscopic 
examination (data not shown).  This condition was used in all further experiments 
described in this thesis. To ensure that the vehicles used to apply the various 
drugs used in this work (see Table 3.1) also did not interfere with ERK1/2 activity, 
a screening of the effects of DMSO, 40% Cyclodextrin, and 100% ethanol was 
also carried out. The results, shown in Fig 4.1B reveal that the levels of total and 
activated ERK1/2 were not changed by any of the vehicle treatments. 
 
A 
 
 
 
 
 
 
 
B 
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Fig. 4.2. CORT dose-dependently alters the levels of activated (pERK) in primary 
hippocampal cultures.  
Cell lysates were immunoblotted were analyzed 20 minutes after treatment of cells with 
various doses of CORT. Total ERK 1/2 levels were unchanged. 
The immunoblot image depicted is representative of at least 3 experiments that yielded 
similar results. * indicates p < 0.05,  **, indicates p < 0.001, both compared to untreated 
(CON) cells. 
Next, experiments were performed to test the dose-dependency and temporal 
effects of CORT on ERK1/2 activation in hippocampal cultures. For this, cells 
were treated with different concentrations of CORT (range from 1 nM to 1 µM) for 
between 0 and 120 minutes. As shown in Fig. 4.2, significant phosphorylation 
(activation) of ERK1/2 was first seen at a CORT dose of 10 nM (p < 0.001) 
without any accompanying changes in the total levels of the (inactive) kinase.  
 
 
 
 
Using this first effective dose of CORT (10 nM), subsequent experiments on the 
time-course of effects showed that the ERK1/2-activating actions of CORT can 
be seen as early as 10 minutes after application of the steroid (Fig. 4.3). 
Maximum increases in phospho-ERK1/2 (pERK) were observed at 20 minutes (p 
< 0.001); these levels returned to baseline after 120 minutes. Analysis of two 
other MAPK family members, p38 and JNK, revealed their significant 
phosphorylation by CORT within 10 minutes, the effects remaining elevated for at 
least 120 minutes (Fig. 4.3).  
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Fig. 4.3. Time course of CORT-induced activation of key MAPK family members.   
Primary hippocampal cells were treated with CORT (10 nM) for between 0 and 120 minutes. 
CORT induced significant increases in the phosphorylation state of ERK 1/2, JNK and p38, 
with maximum activation being seen after 20 minutes of exposure to the steroid. Total ERK 
1/2 level were unchanged.  
The immunoblot image is representative of at least 3 independent experiments. *: P<0.05,  **: 
P<0.001 vs untreated cells.  For reasons of clarity the significance of increases in the 
phosphorylation levels of JNK and P38 are not shown. 
 
 
The above-mentioned earlier studies suggested that the rapid actions of CORT 
could not involve gene transcription (i.e. that CORT has non-genomic actions) 
and/or de novo protein synthesis (Qiu et al., 2001; Qi et al., 2005; Xiao et al., 
2005). Also, those earlier works hypothesized that CORT might act through a 
putative membrane-bound receptor (Qi et al., 2005), similar to hypotheses about 
the actions of other steroid hormones (e.g. estrogen, progesterone; Ke and 
Ramirez, 1990; Revankar et al., 2005) that are well characterized as ligands of 
classical nuclear receptors. Since CORT is small (MW 346.5 g/mol) and lipophilic, 
it rapidly crosses cell membranes; however, it can be made membrane-
impermeable by conjugation to a large protein such as BSA (Xiao et al., 2005; 
2010). Results shown in Fig. 4.4A demonstrate that CORT-BSA is similarly 
effective to unconjugated CORT in stimulating ERK1/2 activation in terms of 
magnitude and temporal pattern of effects. But the peak level of phosphorylated 
ERK1/2 was induced by 100 nM CORT-BSA.  No detectable change induced by 
BSA alone was observed (Fig. 4.4B). 
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B 
 
 
 
 
 
 
 
 
 
 
 
 
To address dependency of the above effects on de novo protein synthesis, 
experiments shown in Fig. 4.5 were carried out in which hippocampal cells were 
exposed to 10 nM CORT in the presence of cycloheximide (CHX; 10 µM), a 
inhibitor of protein translation. The results show that CORT induces pERK1/2 
even in the presence of CHX.  
 
 
 
 
 
 
 
 
Fig. 4.4. Membrane-impermeable CORT-BSA induces ERK 1/2 phosphorylation.  
A. Similarly to unconjugated CORT which can readily permeate the plasma membrane, a 
CORT-BSA conjugate (membrane-impermeable, mainly because of its size (> 65,000 Da) and 
large protein moiety) induced phosphorylation of ERK 1/2 within 20 minutes of application to 
hippocampal neurons in culture. Both CORT and CORT-BSA were applied at a dose of 10 nM 
(with correction for BSA component). B. BSA itself (500 nM, 20 minutes) with/out CORT or 
CORT-BSA did not influence the levels of phosphorylated ERK 1/2. Total ERK 1/2 level were 
not changed in any of the experiments.  
The immunoblots images are representative of at least 3 independent experiments. * indicates 
p < 0.05, ** indicates p < 0.001 vs untreated (CON) cells.   
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4.2 CORT activates Src family kinase signaling pathway 
As described in 1.4.2, protein tyrosine kinase (PTK) plays an important role in the 
cellular signal transduction (Hubbard and Till, 2000). In order to screen for the 
activation of PTK in response to CORT application, the global level of tyrosine 
phosphorylation was assessed in hippocampal neuronal cells. Immunoblots of 
whole-cell lysates, probed with an anti-phosphotyrosine antibody, detected a 
Fig. 4.5. CORT-induced activation of ERK 1/2 does not require de novo protein synthesis. 
The protein synthesis inhibitor, cycloheximide (CHX; 10 µM, 30 minutes) did not affect the 
phosphorylation of ERK 1/2 induced by CORT (10 nM, 20 minutes). Total ERK 1/2 levels were 
unchanged.  
The immunoblot images shown represents results obtained in independent replications (n = 3).  
** denotes p < 0.001 vs untreated (CON) cells.   
In summary, the above results show that primary hippocampal neurons from 
postnatal rats respond to CORT with significant increases in activated ERK1/2 
with 20 minutes. These effects are dose-dependent and do not require the 
synthesis of new proteins. Further, they can also be induced by membrane-
impermeable CORT, supporting the view that a membrane-bound mechanism 
transduces the effects of CORT to cytoplasmic signaling pathways such as 
ERK1/2. Having obtained these data, and given that MAPK signaling pathways 
are likely to lie considerably downstream from the plasma membrane, it was of 
interest to examine the potential involvement of more proximal mechanisms. In 
the next set of experiments therefore, the Src family kinase signaling pathway 
was analyzed. 
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large number of bands in the range of 20-200 kDa that were significantly 
upregulated within 5 minutes of CORT application at a dose of 10 nM (p < 0.05); 
tyrosine phosphorylation levels peaked at 20 minutes (p < 0.001) and thereafter 
decreased slowly although they were still significantly higher (p < 0.05) than 
under basal conditions after 60 minutes (Fig 4.6A). Notably, the effects of CORT 
on tyrosine phosphorylation were not prevented by the presence of the protein 
synthesis inhibitor, cycloheximide (CHX), implying a signaling mechanism that 
does not require classical transcriptional mechanisms (Fig 4.6B).  
A 
 
 
 B 
 
 
 
 
Fig. 4.6. Rapid induction of phosphorylation of protein tyrosine kinases (PTK) by CORT. 
A: The levels of phosphorylated PTK (p-Tyr-100) were significantly increased after 5 minutes 
of CORT treatment (10 nM), and were sustained above control levels for at least 60 minutes. 
B. The phosphorylation of PTK induced by CORT (10 nM, 20 min) was not affected by 
cycloheximide (CHX; 10 µM, 30 minutes).  
The blots shown are representative of at least 3 experiments, all of which gave similar results. 
*: P<0.05, **: P<0.001 vs untreated (CON) cells.   
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Next, small molecule inhibitors of non-receptor protein kinases (NRTK) were 
screened in an attempt to identify the candidate PTK that could be potentially 
responsible for the observed CORT-induced increases in phosphotyrosine levels.  
Specifically, we tested a Src family kinase inhibitor (PP2), an inhibitor of Abl 
(imatinib, STI-571), as well as inhibitors of the JAK-STAT and Syk pathways (Fig 
4.7A); in addition, two receptor tyrosine kinase (RTK) inhibitors were tested: a 
TrkB inhibitor (K252a) and an epidermal growth factor (EGF) inhibitor (AG1478) 
(Fig 4.7B). Apart from PP2 which completely abolished the CORT-triggered 
upregulation of phosphotyrosine, none of the other inhibitors tested exerted a 
significant effect on the ability of CORT to influence this parameter. Importantly, 
PP3, an inactive analog of PP2 did not significantly interfere with the actions of 
CORT Fig 4.7C). These findings point to a central role of the Src family kinases 
in mediating the actions of CORT that originates at the plasma membrane. 
Indeed, this view is supported by additional data obtained when a structurally 
unrelated (compared to PP2) Src-family inhibitor (SU6656) was used Fig 4.7C.  
 
The importance of Src family activation was next further explored. 
Immunoblotting assays confirmed that CORT efficiently upregulates of Src 
phosphorylation and revealed that this occurs at Y416, a tyrosine residue which 
determines the activation of the kinase (Fig 4.8A). This activation was detectable 
within 10 minutes of CORT application at a dose of 10 nM (p < 0.05), with peak 
activation being seen after 30 minutes (Fig 4.8A). Interestingly, phosphorylation 
of Y527, an epitope responsible for triggering an the auto-inhibitory loop 
(Roskoski, 2005), was not immediately affected (10  minute time-point) although 
phosphorylation of this epitope was significantly reduced after 30 and 60 minutes 
of exposure to CORT (Fig 4.8B). It should be noted that the levels of total Src 
were not influenced by any of the above treatments (not shown). 
RESULTS 
 
 - 65 -
A 
 
B 
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Fig. 4.7. Small molecule inhibitors of PTK screening. A. Hippocampal neuronal cultures 
were pretreated with various inhibitors of non-receptor protein kinase for 30 minutes before 
CORT application (10 nM, 20 minutes). Only the Src inhibitor, PP2 (1 µM) significantly 
abrogated the ability of CORT to induce PTK phosphorylation. The Abl inhibitor (STI, 1 µM), 
JAK-STAT inhibitor (JI, 1 µM) and Syk inhibitor (SI, 1 µM) were non-effective at preventing PTK 
phosphorylation by CORT. B. Two receptor protein kinase inhibitors, the EGF inhibitor AG1478 
(10 µM, 30 minutes) and TrkB inhibitor K252a (1 µM, 30 minutes) also did not counteract the 
actions of CORT. C. The inactive analogue of PP2, PP3 (1 µM, 30 minutes), failed to inhibit 
CORT-induced phosphorylation of PTK, but another Src family inhibitor, SU 6656 (1 µM, 30 
minutes) yielded results that were similar to those found with PP2.  
The immunoblots shown are representative of results obtained in at least 3 independent 
experiments. *: P<0.05, **: P<0.001 vs untreated (CON) cells.  #: P<0.05 vs CORT-treated cells.  
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4.3 Pyk2 phosphorylation mediates CORT-induced Src activation 
In neurons, the Src family kinases are activated by a large number of stimuli and 
mechanisms (Kalia et al. 2004), with the PTK-scaffold protein Pyk2 being 
identified as a leading direct activator of Src (Huang et al., 2001). In light of this, 
Fig. 4.8. CORT rapidly activates Src. A:  After CORT treatment (10 nM), the phosphorylation 
level of Src tyrosine site 416 (Y416) was significantly increase from as early as 10 minutes 
and peaked at 30 minutes. B: Within 30 minutes of treatment, CORT significantly induced the 
dephosphorylation of Src at tyrosine site 527 (Y527). The total levels of Src level were not 
affected by CORT (not shown).  
The image of Western blot represents results obtained in at least 3 independent experiments. 
*: P<0.05, **: P<0.001 vs untreated (CON) cells.  
Together, the above sets of results established activation of the Src kinase 
family as an essential step in the rapid signaling effects of CORT and provided 
the impetus to follow this line of investigation further.  
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Pyk2 was next investigated as a player in the mechanisms leading to the 
manifestation of rapid actions of CORT. 
As shown in Fig 4.9A, CORT was found to cause robust activation of Pyk2 for 
between 10 and 30 minutes after application; this was evidenced by increased 
phosphorylation of the Y402 residue in Pyk2. Further, CORT-induced activation 
of Src was prevented in the presence of PF431396, a selective inhibitor of the 
Pyk2 kinase (Fig 4.9B), confirming a major role of Pyk2 in CORT-induced Src 
family activation.  
 
A
 
B 
 
 
Fig. 4.9. Phosphorylation of Pyk2 occurs rapidly CORT application to hippocampal 
neurons. A: CORT (10 nM) induced the phosphorylation of Pyk2 at the tyrosine site 402 
(Y402) epitope within 10 minutes of application(peaking after 30 minutes, while total levels of 
Pyk2 were unchanged. B: The Pyk2 inhibitor, PF431396 (3 µM, 30 minutes), abolished the 
CORT-induced phosphorylation of Src Y416, indicating regulation of Src activation by Pyk2. 
Immunoblots are representative of at least 3 different experiments. *: P<0.05, **: P<0.001 vs 
untreated (CON) cells.  #: P<0.05 vs CORT treated cells.   
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 Confirmation that CORT induces phosphorylation of Pyk2 was obtained by 
immunocytochemical analysis. For this, hippocampal neurons were subject to 
immunostain with a specific anti-Pyk2 antibody. Whereas only weak immuno-
reactivity was detectable in the soma and nucleus in cells under baseline 
conditions, CORT (10 nM) treatment caused a marked increase in the intensity of 
immunostaining (Fig 4.10A); in the latter case, the Pyk2 staining was punctuate 
and was seen to occur in distinct clusters along dendrites (Fig 4.10B).  
A 
 
 
B 
 
 
 
Fig. 4.10. Immunostaining of hippocampal cultures for pPyk2 (Y402). A: Treatment with 
10 nM CORT (30 minutes) caused an increase in the intensity of immunostaining of the Pyk2 
that was phosphorylated at tyrosine residue 402 (Y402). Immunoreactivity was observed in 
both, cell soma and nuclei. Scale bar represents 20 µm B: CORT application (10 nM, 30 
minutes) caused a significant increase in the punctuate staining of pPyk2 (Y402), suggesting 
that Pyk2 activation was taking place in discrete subdomains along dendrites. Scale bar 
represents 2 µm 
**: P<0.001 vs untreated (CON) cells.   
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The activation of Pyk2 was further characterized by analyzing the 
phosphorylation of four phospho-epitopes: the autophosphorylation site Y402, 
the kinase domain sites Y579 and Y580 (whose phosphorylation is required for 
full kinase activity) and Y881 (located in the C-terminal FAT domain). CORT was 
found to significantly trigger the phosphorylation of all four tyrosine residues (Fig 
4.11). Phosphorylation on Y402 (site of autophosphorylation; Park et al., 2004) 
proved sensitive to blockade with PF431396 (Pyk2 inhibitor), but not Src 
inhibitors, PP2. On the other hand, phosphorylation of the Y579 residue was 
found to depend on activated Src since it was prevented when cells were co-
treated with PP2. Importantly, CORT-induced phosphorylation on Y580 and Y881 
was only partially affected by Src blockade (Fig 4.11), indicating the existence of 
additional regulatory mechanisms for the phosphorylation of these tyrosine 
residues.  
 
 
 
 
 
 
 
Fig. 4.11. Analysis of phosphorylated Pyk2 epitopes after CORT treatment of 
hippocampal cultures. The phosphorylation levels of all four Pyk2 phosphoepitopes were 
significantly increased after CORT treatment (10 nM, 20 minutes). These events were 
abolished by pretreatment with the Pyk2 inhibitor PF431396 (PF, 3 µM, 30 minutes). The Src 
inhibitor PP2 (1 µM, 30 minutes) did not inhibit phosphorylation of Y402, but fully blocked 
phosphorylation of Y579 and partly blocked phosphorylation of the Y580 and Y881 residues. 
The inactive analogue of PP2, PP3, did not exert any effects on any of the potentially 
phosphorylable Pyk2 epitopes. None of the treatments influenced the levels of total Pyk2.  
The Western blot image shown is representative of at least 3 different experiments. *: P<0.05, 
**: P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT treated cells.   
The above sets of data strongly suggest that activation of Pyk2, a downstream 
target of Src kinase, is likely to be a key mediator of the fast, non-genomic 
signalling cascade triggered by CORT at the plasma membrane.  
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4.4 PLC-PKC, PKA and PKB-dependent pathways mediate 
CORT-induced activation of Pyk2 in a convergent manner  
Previous work has shown that Pyk2 is a signaling hub that is activated by 
multiple pathways and second messengers, most of which are Ca2+- and PKC-
dependent (Avraham et al., 2000). Here, CORT-induced autophosphorylation of 
Pyk2 on Y402 was shown to be mediated by the PLC-PKC signaling cascade; 
specifically, and as depicted in Fig. 4.12A, Pyk2 phosphorylation on Y402 was 
prevented when hippocampal neurons were treated with inhibitors of either PLC 
inhibitor (U 73122), PKC (Gö 6983) or Calmodulin (W7). Moreover, these events 
were shown to depend on the mobilization of intracellular Ca2+ stores: blockade 
of Ca2+ release by either a Ca2+ chelator (BAPTA-AM) or IP-3 receptor antagonist 
(2-APB) significantly abrogated CORT-induced activation of Pyk2 and Src (Fig 
4.12B). Reciprocally, short-term application of the Ca2+ pump blocker 
thapsigargin (whose acute application results in increased Ca2+ release) 
mimicked the effects of CORT, as seen by the increased phosphorylation of Pyk2 
and Src following application of the steroid (Fig 4.12B).  
Further analysis in which the non-genomic CORT-induced autophosphorylation 
of Pyk2 was investigated by using inhibitors of either PKA (PI and H89), PI-3K 
(wortmannin) or PKB (API-2). The results indicated that PKC is the sole regulator 
of CORT-induced Pyk2 autophosphorylation since none of the above inhibitors 
were able to effectively abrogate the actions of CORT (Fig 4.13A). Given that 
autophosphorylation on Y402 is the earliest event in Pyk2 phosphorylation (Park 
et al., 2004), it was not surprising to find that the PKC inhibitor Gö 6983 also 
blocked he phosphorylation on Y579, Y580 and Y881 (Fig 4.13B-D). Interestingly, 
however, a different picture emerged upon inspecting the effects of PKA and PKB 
on the Y579 and Y580 phosphoepitopes on Pyk2. Both, PKA and PI-3K/PKB 
inhibitors prevented CORT-induced phosphorylation of these residues which are 
located in the kinase activation loop and whose phosphorylation is required for 
full kinase activity (Fig 4.13B and 4.13C). Thus, it would appear that CORT 
recruits other regulatory pathways that impinge on these sites.  
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Another important finding from this set of experiments was that, although 
phosphorylation of the Y881 site occurs independently of PKA but depends on 
activation of the PI-3K/PKB pathway; specifically, while H89 did not prevent 
CORT-induced phosphorylation at Y881, both wortmannin and API-2 abrogated 
the actions of CORT at this phospho-epitope (Fig 4.13D). The demonstrated role 
of PKA and PKB in the regulation of phosphorylation of Pyk2 tyrosine residues 
implies involvement of an additional mediator. Accordingly, in a subsequent step, 
we tested the importance of PTP-PEST (see Chapter 1) since this molecule was 
previously shown to regulate Pyk2 (Lyons et al., 2001; Davidson et al., 2010).  
Fig. 4.12. The role of PLC-PKC and calcium ions in the actions of CORT.  A: The 
phosphorylation of Pyk2 Y402 by CORT (10 nM, 20 minutes) was significantly inhibited by the 
pharmacological inhibitors of PLC (U 73122; U, 5 µM), PKC (Gö 6983; Gö. 5 µM) and 
calmodulin (W7, 50 µM), all present for 30 minutes. B: The Ca2+ chelator BAPTA-AM (BA. 13 
µM) and IP-3 receptor antagonist 2-APB (100 µM) both prevented CORT-induced 
phosphorylation of Pyk2 Y402 and Src Y416 (both drugs available for 30 minutes). However, 
the Ca2+ pump blocker thapsigargin (TG, 1 µM, 30 minutes) acted like CORT in inducing 
phosphorylation of Pyk2 Y402.  
The immunoblots shown represent results from at least 3 different experiments. *: P<0.05, **: 
P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT treated cells (CORT).   
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Fig. 4.13. The role of PKC, PKB and PKA in regulating Pyk2 epitope phosphorylation.  
A. The CORT-triggered (10 nM, 20 minutes) phosphorylation of Pyk2 at Y402 was significantly 
inhibited by a PKC inhibitor (Gö 6983, Gö, 5 µM, 30 minutes), but not by inhibitors of PI3K 
(wortmannin, WO 4 µM, 30 minutes), PKB (API-2, API. 30 µM, 30 minutes) or PKA (H89, 1 
µM, 30 minutes). B. All of inhibitors abolished the ability of CORT to induce phosphorylation of 
Pyk2 at Y579 and C, all inhibitors exerted similar effects on Pyk2 Y580. D: The Pyk2 Y881 
phosphorylation induced by CORT was inhibited by inhibitors of PKC, PI3K and PKB, but not 
by inhibitors of PKA.   
Th immunoblot shown is representative of at least 3 separate experiments. *: P<0.05, **: 
P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT treated cells.   
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Results shown in Fig. 4.14A demonstrate that CORT (10 nM) induces 
phosphorylation of PTP-PEST at serine 39 (S39) within 5 minutes of application 
(peak of effect at 20-30 minutes). Importantly, phosphorylation of this specific site 
has previously been reported to result in an inhibition of PTP-PEST activity 
(Garton and Tonks, 1994; Nakamura et al., 2010). Notably, inhibitors of both PKA 
and PKB prevented CORT-induced PTP-PEST phosphorylation in hippocampal 
neurons (Fig 4.14B). 
 
A 
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Fig. 4.14. Role of the cytoplasmic protein tyrosine phosphatase, PTP-PEST.  A. Treatment of 
hippocampal cultures with CORT (10 nM) induced phosphorylation of PTP-PEST at serine 39 
(S39) within 5 minutes and the effect peaked at 20-30 minutes. B: The inhibitors of PI3K 
(wortmannin, WO, 4 µM, 30 minutes), PKB (API, 30 µM, 30 minutes) and PKA (H89, 1 µM, 30 
minutes) abolished the above response to CORT. 
The immunoblots are representative of at least 3 independent experiments. *: P<0.05, **: P<0.001 
vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT treated cells.   
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4.5 Involvement of a membrane-bound G-protein coupled 
receptor in the rapid signaling effects of CORT 
The above-described involvement of the PLC-PKC and PKA pathways in the fast 
actions of CORT raised the intriguing possibility that a G-protein-mediated 
mechanism may initiate the non-genomic rapid signaling actions of CORT. To 
address this, hippocampal neuronal cells were treated with GDP-β-S, a non-
hydrolysable GDP analogue that traps G-proteins in an inactive conformation. 
This treatment blocked the ability of CORT to induce phosphorylation of Pyk2 
and Src (Fig 4.15A), a result that strongly pointed to involvement of G-proteins. 
This view was further confirmed in experiments in which hippocampal neurons 
were exposed to CORT in the presence or absence of pertussis toxin (PTX), a 
potent inhibitor of Gi/o proteins, as depicted in (Fig 4.15B).  
To strengthen the hypothesis that a G-protein coupled receptor (GPCR) might 
mediate the fast, non-genomic actions of CORT, studies were next performed 
using cell-impermeable CORT-BSA. The latter triggered both Pyk2 and Src 
phosphorylation to the same extent as unconjugated CORT, albeit in a PTX-
sensitive manner; this action of CORT-BSA was also subject to inhibition when a 
PKC inhibitor (Gö 6983) was co-applied (Fig 4.16).  
In contrast, CORT-BSA-activated signaling persisted even in the presence of 
antagonists of classical (nuclear) GR (RU38486 and J2700) and MR (RU28318, 
Eplerenone and Spironolactone), as shown in Fig 4.17A. In addition, a novel GR  
To sum up, the above series of experiments suggest that Pyk2 is activated 
within a short time of exposure of hippocampal neurons to CORT. This 
activation of Pyk2 occurs through the participation of several signalling 
pathways: one, the PLC-PKC pathway induces autophosphorylation of Pyk2; 
the other pathways involved are PKA and PKB pathways which appear to 
regulate Pyk2 activity by inhibiting the activity of PTP-PEST.  
RESULTS 
 
 - 75 -
A 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.16. A cell impermeable CORT-BSA conjugate (10 nM, 20 minutes) rapidly induced the 
activation of both Pyk2 and Src, effects that were blocked by pertussis toxin (PTX, 500 ng/mL, 120 
minutes)  an inhibitor of  Gi/o proteins and Gö 6983, Gö (5 µM, 30 minutes) a PKC inhibitor.  
The immunoblot shown is representative of at least 3 individual experiments. *: P<0.05, **: 
P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT-BSA treated cells.  
Fig. 4.15. Involvement of a G-protein-mediated mechanism.  A.  Treatment of hippocampal 
cells with the non-hydrolysable GDP analogue, GDP-β-S (100 µM, 30 minutes), abolished CORT-
induced phosphorylation of both Pyk2 Y402 and Src Y416. B. Similar results were obtained after 
treatment with Gi/o protein inhibitor, pertussis toxin (PTX, 500 ng/mL, 120 minutes).  
The images shown are representative of results obtained in at least in at least 3 independent 
experiments. *: P<0.05, **: P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT 
treated cells (CORT).
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antagonist, CORT 108297, failed to influence the effects of both CORT and 
CORT-BSA in terms of activation of Pyk2 and Src (Fig 4.17B).   
A 
 
B 
 
 
 
Fig. 4.17. Lack of effects of antagonists of nuclear GR and MR. A. Co-incubation of 
cells with CORT-BSA and either nuclear GR (RU 486 and J2700, 100 nM, 30 minutes) 
or nuclear MR (RU28318, Eplerenone and Spironolactone,100 nM, 30 minutes) 
antagonists suggested that nuclear GR and MR are not required for manifestation of the 
rapid phosphorylation of Pyk2 Y402 and Src Y416 by CORT-BSA (10 nM, 20 minutes); 
these drugs also did not exert any effect on the actions of CORT (not shown). B. 
Similarly, a novel GR antagonist (CORT 108297, 100 nM, 30 minutes) did not affect the 
rapid effects of either CORT or CORT-BSA. 
The immunoblot images are representative of results obtained in at least 3 experiments. 
*: P<0.05, **: P<0.001 vs untreated (CON) cells. 
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However, both CORT- and CORT-BSA-induced phosphorylation of Pyk2 and Src 
was prevented when cultured hippocampal neurons were treated in the presence 
of G15, a novel antagonist of the putative GPCR (termed GPR30) that is 
increasingly considered to mediate estrogen signaling at the cell surface (Fig 
4.18).  
 
 
 
 
 
 
 
 
 
 
Fig. 4.18. Attenuation of the induction of Pyk2 Y402 and Src Y416 by CORT and CORT-
BSA by G15. The antagonist of the G-protien-coupled receptor GPR30, G15 (1 µM, 30 
minutes) caused a significant reduction of the effects of CORT and CORT-BSA on the 
induction of Pyk2 Y402 and Src Y416, suggesting mediation of the steroid effects by GPR30-  
A representative immunoblot from at least 3 independent experiments is shown. *: P<0.05, **: 
P < 0.001 vs untreated (CON) cells. #: P<0.05, ##: P<0.001 vs CORT or CORT-BSA treated 
cells.  
 
Together, the evidence described here goes against the idea that classical 
(nuclear) receptors (GR or MR) mediate the rapid actions of CORT on 
intracellular signalling pathways. Rather, the results presented in this section 
imply that the fast actions of CORT are mediated by a Gi/o protein. Moreover, 
the data suggest that the GPCR that mediates CORT actions at the plasma 
membrane maybe be identical, or very similar, to GPR30.  
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4.6 Pyk2 mediates CORT induces activation of c-Abl and RhoA 
Lying downstream of many GPCR, the cellular oncogene c-Abl is a non-receptor 
tyrosine kinase. It is localized in dynamic actin structures where, by 
phosphorylating various target proteins, it serves to regulate cytoskeleton 
remodeling in many contexts, including cell differentiation, cell division and cell 
adhesion. Very recently, c-Abl has been implicated in Alzheimer’s disease 
pathology since it is a potent Tau kinase (Schlatterer et al., 2011). The latter 
authors noted that c-Abl is only found in neurons (not in glial cells) and 
suggested its activation might depend on neuronal activity. Lastly, in the context 
of the present work, it is worth mentioning that c-Abl is recruited to the 
phosphorylated Y881 site of Pyk2 (Zrihan-Licht et al., 2004), making it a relevant 
candidate for further investigation. 
Here, hippocampal neurons were treated with CORT (10 nM) up to 60 minutes 
and the levels of active c-Abl (i.e. phosphorylated on Y412) were probed using a 
phospho-specific antibody. Application of CORT triggered c-Abl phosphorylation 
within 20 minutes and peak (> 3-fold) increases were observed after 60 minutes. 
Temporally, the increase in activated c-Abl was delayed in comparison to that of 
phospho-Pyk2 and phospho-Src whose upregulation was detectable 5-10 
minutes after treatment of neurons with CORT (Fig 4.19A). In fact, as shown in 
Fig 4.19B, activation of c-Abl required Pyk2 and Src activity: the appearance of 
activated c-Abl was blocked in the presence of inhibitors of Pyk2 (PF431396) and 
Src (PP2).  
 
Interestingly, the specific antagonist of NMDAR, MK801, failed to inhibit CORT-
induced activation of c-Abl (Fig 4.19C). This observation indicates that the 
actions of CORT do not depend on activation of the NMDA receptor (NMDAR) 
and that the non-genomic signaling cascade triggered by CORT involves 
activation of c-Abl through Pyk2 and Src kinases.   
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Fig. 4.19. c-Abl is a further downstream target of CORT actions.  A. Exposure of 
hippocampal cultures to CORT (10 nM) was followed by a rapid increase (within 20 minutes) 
in the levels of phosphorylated c-Abl Y412; the increase in phosphorylated c-Abl Y412 
reached a peak after 60 minutes.  B. Both, a Pyk2 inhibitor (PF431396, 3 µM, 30 minutes) and 
an inhibitor of Src (PP2, 1 µM, 30 minutes) abolished this CORT-induced effect on CORT-
induced c-Abl. C. The NMDAR antagonist, MK801 (10 µM, 30 minutes) did not inhibit the 
activation of c-Abl by CORT.  
The immunoblot images shown are representative of at least 3 experiments. *: P<0.05, **: 
P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT treated cells.   
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Since Abl is a major regulator of the actin cytoskeleton (Colicelli, 2010) and of the 
postsynaptic density (PSD; de Arce et al., 2010), the ability of CORT to influence 
integrity of the PSD through the mediation of activated c-Abl. To this end, 
hippocampal neurons were treated with CORT (10 nM, 30 minutes) for detecting 
the expression of drebrin, an F-actin binding protein was monitored by confocal 
microscopy (Takahashi et al., 2006). At baseline, immunostained drebrin was 
largely punctuated and strongly apposed to synapsin-positive puncta, as 
predicted by the localization of drebrin in dendritic spines (Fig 4.20A). Drebrin 
immunoreactivity in the dendritic spines was strongly enhanced in the presence 
of CORT (Fig 4.20B), with a marked increase in the spine-to-shaft ratio. 
Importantly, inhibitors of Pyk2 and Src kinases prevented these effects of CORT 
(Fig 4.20C,D), as did the c-Abl inhibitor (STI-571) (Fig 4.20E); notably, STI-571 
also reversed the spine-to-shaft gradient of drebrin localization. In parallel, CORT 
triggered an increase in PSD-95 cluster size (Fig 4.21F,G), an effect that was 
prevented by pharmacological inhibition of Pyk2, Src and c-Abl (Fig 4.21H-J).  
 
RhoA, a member of the small GTPase Rho family, has been extensively studied 
for its role in cellular processes and functions, including remodeling of the actin 
cytoskeleton (Etienne-Manneville and Hall, 2002).  Using an advanced enzyme-
linked immunosorbent assay for small GTPase, RhoA activation was shown to be 
detectable in cultured hippocampal neuronal cells. As shown in Fig 4.21, RhoA 
activation was significantly increased in cells pretreated with CORT (10 nM, 30 
minutes) compared to normal cells. This effect of CORT was abolished by the 
inhibitors of G-proteins (PTX), Pyk2 (PF431396) and Src (PP2), but not by the c-
Abl inhibitor, STI-571, suggesting that the RhoA activation pathway induced by 
CORT is regulated by G-protein and Py2/Src kinases, but not by c-Abl kinase. 
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Fig. 4.20. Confocal microscopical analysis of drebrin and PSD-95 immunostaining in 
hippocampal cultures.  A:  Under baseline conditions, drebrin co-localized with synapsin-
positive puncta in dendritic spines. B: Exposure of cultures to CORT (10 nM, 30 minutes) 
resulted in enhanced the drebrin immunoreactivity and increased size of drebrin clusters. C: 
The effects of CORT were abolished by the Pyk2 inhibitor PF431396 (PF, 3 µM, 30 minutes) 
and, as shown in D, by the Src inhibitor (PP2, 1 µM, 30 minutes). E: The c-Abl inhibitor, STI-
571 (STI, 1 µM, 30 minutes) also abrogated the effects of CORT. Scale bar represents 2 µm. 
Similar effects were also observed in immunostaining of PSD-95: F. PSD-95 cluster size in 
dendritic spine of normal hippocampal cells. G: CORT (10 nM, 20 minutes) significantly size of 
PSD-95 clusters. H: The effects of CORT were attenuated by the Pyk2 inhibitor PF431396 
(PF, 3 µM, 30 minutes), I, by the Src inhibitor (PP2, 1 µM, 30 minutes), and J, by he c-Abl 
inhibitor, STI-571 (STI, 1 µM, 30 minutes).  Scale bar represents 2 µm. 
*: P<0.05, **: P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001vs CORT treated 
cells (CORT).   
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Fig. 4.21. Measurement of RhoA activation using GLISA kit.  RhoA activation was 
significantly increased after CORT treatment (10 nM, 30 minutes). The inhibitors of G-protein 
(PTX, PTX, 500 ng/mL, 120 minutes), Pyk2 (PF431396, 3 µM, 30 minutes) and Src (PP2, 1 
µM, 30 minutes) abolished this effect, but c-Abl inhibitor, STI-571 (1 µM, 30 minutes), did not 
affect RhoA activation. The experiments were repeated three times in independent cultures. 
The results are presented in terms of relative luminescence units (RLU). POS: positive control, 
provided by kit manufacturer.  
*: P<0.05 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001vs CORT treated cells (CORT).   
The data presented in this section show that CORT sequentially activates 
Pyk2, Src and c-Abl. These events do not require activation of NMDAR. The 
activation of c-Abl has an impact on both drebrin and PSD structures, most 
likely through the actin cytoskeleton-remodelling actions of c-Abl. Additionally, 
the activation of RhoA is caused by CORT, through a Pyk2/Src-regulated but 
c-Abl-independent pathway. 
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4.7 Functional consequence of non-genomic CORT signaling in 
hippocampal neurons  
Having identified several key events in the non-genomic signaling cascades 
initiated by CORT, potential functional endpoints of the cascade was investigated. 
Given the above-mentioned changes in PSD structure, the study focused on the 
NMDAR. Previous work suggests that NMDAR subunits are the most abundant 
phosphotyrosine proteins present in synapses (Trinidad et al., 2008) and, at the 
same time, are substrates of several Src family kinases. It is also known that 
tyrosine phosphorylation of the NR2 subunit regulates NMDAR trafficking and 
membrane insertion (Salter and Kalia, 2004). The question asked here was 
whether CORT affect NMDAR trafficking and clustering through tyrosine kinase 
activation.  
The above question was addressed by treating cultured hippocampal neurons 
were treated with CORT (10 nM) before immunostaining surface NR1 subunits 
under non-permeabilizing conditions using a monoclonal antibody directed 
against the extracellular epitope of NR1. It was found that 20 minutes treatment 
with 10 nM CORT markedly upregulates surface NR1 levels (Fig 4.22A,C) as 
well as synaptic NR2B (Fig 4.22B,D).  These increases are subject to abrogation 
by inhibitors of Pyk2 and Src, but not by the inhibitor of c-Abl (ST-571). In support 
of these results, it was also found that CORT increases the phosphorylation of 
Y1472 on the cytoplasmic tail of the NR2B subunit, an event known to block 
endocytosis and increases surface trafficking of the receptor (Lavezzari et al., 
2004; Goebel et al., 2005).  
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Fig. 4.22. Immunostaining of surface NR1 and synaptic NR2B in hippocampal neuronal 
cultures treated with CORT. A, C Surface expression of NR1 was significantly increased 
after CORT treatment (10 nM, 20 minutes) in manner that was sensitive to inhibition by 
inhibitors of Pyk2 (PF431396; PF, 3 µM, 30 minutes) Src (PP2; 1 µM, 30 minutes). However, 
the c-Abl inhibitor, STI-571 (STI, 1 µM, 30 minutes) did not interfere with the actions of CORT. 
Scale bar represents 2 µm.  B, D Similar effects were observed upon inspection of synaptic 
expression of NR2B; specifically, CORT induced synaptic levels of NR2B that were subject to 
inhibition by inhibitors of Pyk2 and Src, but not of c-Abl. Scale bar represents 2 µm. 
*:P<0.05,  **: P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT-treated 
cells.   
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The latter effect is sensitive to inhibition by inhibitors of both Pyk2 and Src, but 
not of c-Abl (Fig 4.23A). Additionally, CORT-induced phosphorylation of NR2B 
Y1472 was abolished by another Src inhibitor SU6656, but not by PP3, an 
inactive form of the Src inhibitor PP2, further confirming the regulatory role of Src 
kinase in NR2B Y1472 phosphorylation (Fig 4.23B).  
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Fig. 4.23.  Phosphorylation of NR2B Y1472 induced by CORT. A. Treatment of 
hippocampal cultures with CORT (10 nM, 20 minutes) led to an increase in the levels of 
phosphorylated NR2B at tyrosine site 1472 (Y1472), an effect abolished by both a Pyk2 
inhibitor (PF431396, 3 µM, 30 minutes) and Src inhibitor (PP2, 1 µM, 30 minutes), but not the 
inhibitor of c-Abl inhibitor, STI-571 (STI, 1 µM, 30 minutes). B. Both Src inhibitors, SU6656 
(SU, 1 µM, 30 minutes) and PP2 (1 µM, 30 minutes), inhibited CORT-induced NR2B 
phosphorylation; PP3 (1 µM, 30 minutes), the inactive analogue of PP2, had no effect.   
The Western blot images are representative of at least 3 independent experiments. *: P<0.05, 
**: P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT treated cells.   
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As a consequence of the CORT-upregulated surface expression, there was a 
significant increase in the levels of activated ERK1/2 (Fig 4.24A), which was 
mentioned in Section 4.1. This increase was completely blocked when the 
NMDAR antagonist MK801 was present (Fig 4.24B).  
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Fig. 4.24. CORT induction of ERK phosphorylation. A. CORT (10 nM) stimulated ERK 1/2 
phosphorylation within 5 minutes of application, the maximum effects occurring at 20 minutes. 
B. The activation of ERK 1/2 was completely abrogated in the presence of the NMDAR 
antagonist, MK801 (10 µM, 30 minutes).  
The immunoblot images are representative of at least 3 experiments. *: P<0.05, **: P<0.001 
vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs CORT treated cells.   
RESULTS 
 
 - 87 -
Interestingly, when hippocampal neurons that had been pretreated with CORT 
(10 nM, 20 minutes) were challenged with NMDA (100 nM, 5 minutes), resulted 
in only a minor change (no significant change was observed) in the levels of 
phosphorylated ERK 1/2 phosphorylation (Fig 4.25); this observation suggests 
that the initial exposure to CORT occluded further agonist-induced NMDAR 
activation.  
 
 
 
 
 
 
Fig. 4.25. NMDAR activation produces effects on ERK 1/2 phosphorylation that are 
similar to those observed with CORT. Hippocampal cultures exposed to NMDA (100 nM, 5 
minutes) showed an induction of ERK 1/2 phosphorylation. However, application of NMDA 
(100 nM, 5 minutes) after initial treatment with CORT (10 nM, 20 minutes) did not elicit a 
greater response than either drug alone.  
The immunoblot image is representative of at least 3 independent experiments. *: P<0.05, **: 
P<0.001 vs untreated (CON) cells.   
Together, this last set of data show that CORT actions at the neuronal plasma 
membrane can lead to tyrosine phosphorylation of NR2B; this results in an 
upregulation of the amount of NMDAR on the cell surface and amplification of 
the NMDAR-mediated signalling cascade.  
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4.8 The activation of MAPK cascade and transcriptional events. 
As mentioned in Section 4.1, CORT rapidly induces phosphorylation of all three 
MAPK family members. One of them, ERK 1/2 is known to induce synaptic 
plasticity in the hippocampus in an NMDAR-dependent manner (Kaphzan et al. 
2006).  Since CORT-induced ERK 1/2 phosphorylation was abolished in the 
presence of the NMDAR antagonist, MK801, and not increased after further 
challenging with NMDA after CORT treatment, it appears that the activation of 
ERK 1/2 induced by CORT is mediated by a cascade of events downstream of 
the NMDAR. As CaMKII, an NMDAR-associated protein (Yan et al. 2011) was 
previously shown to regulate activation of ERK/MAPK signaling in PC 12 cells 
(Liu et al. 2009), the involvement of this kinase was investigated next. 
 
Treatment of hippocampal neuronal cultures with CORT (10 nM) rapidly induced 
phosphorylation of CaMKII at the autophosphorylation threonine 286 site (T286) 
that allows full kinase activity (Yang and Schulman, 1999), with a peak increase 
appearing as early as 5 minutes (Fig 4.26A) after application of CORT. 
Importantly, the CORT-induced effect was attenuated by MK801, the NMDAR 
antagonist (Fig 4.26B), indicating NMDAR mediation of the effect.  
 
The cAMP response element-binding (CREB), an important transcription factor in 
neurons, has been reported to be regulated by synaptic NMDAR and to play an 
important role in transcription-dependent memory and cognitive functions 
(Hardingham et al. 2001).  To investigate the impact of CORT on CREB, 
inhibitors of CaMKII (CI), RAF (GW 5074) and MAPK (PD98059 and U0126) 
were applied in combination with CORT (10 nM, 20 min). As shown in Fig 4.27A, 
CORT-induced phosphorylation of CaMKII was inhibited by the CaMKII inhibitor, 
but not by the inhibitors of RAF and MAPK; Further, the CORT-induced activation 
of ERK 1/2 was attenuated in the presence of inhibitors of CaMKII and RAF and 
abolished in the presence of both MAPK inhibitors (Fig 4.27B). Lastly, CORT 
induced significant phosphorylation of CREB, an effect that was abrogated by all 
of four inhibitors (Fig 4.27C).   
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Another ERK- related transcription factor, early growth response-1 (Egr-1), has 
been described as of possible target of activated GR (Revest et al. 2005).  Here, 
10 nM CORT induced an increase in the expression levels of Egr-1 in 
hippocampal neuronal cultures. As shown in Fig 4.28, the first significant 
increase appeared at 30 minutes, peaked at 60 minutes, and slightly decreased 
at 120 minutes. 
 
 
Fig. 4.26. CORT induces phosphorylation of CaMKII. A: CORT (10 nM) induced a 
significant increase in the phosphorylation of CaMKII at its threonine 286 site (T286) within 5 
minutes of application.  B. The CORT-induced phosphorylation of CaMKII was inhibited by the 
NMDAR antagonist, MK801 (10 µM, 30 minutes).  
The immunoblot images are representative of results obtained in at least 3 different 
experiments. *: P<0.05, **: P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs 
CORT treated cells.   
These results show that CORT-induced phosphorylation of the transcription 
factor CREB is regulated via a CaMKII-MAPK mechanism that lies 
downstream of NMDAR.  CORT also stimulated Egr-1 expression, which was 
suggested to be a GR-targeted transcription factor. Thus, it appears that 
membrane and nuclear signalling mechanisms can converge. 
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Fig. 4.28. CORT at a dose of 10 nM was sufficient to enhance the expression of Egr-1, an 
ERK 1/2 target gene. The first significant increase appeared at 30 minutes, peaked at 60 
minutes, and was maintained at levels significantly higher than under baseline conditions for 
at least 120 minutes. 
The immunoblot shown is representative of results obtained in at least 3 experiments. *: 
P<0.05, **: P<0.001 vs untreated (CON) cells.  
Fig. 4.27. CaMKII and MAPK mediate the effects of CORT on CREB phosphorylation. A. 
CORT (10 nM, 20 minutes) induced a significant increase in the phosphorylation of CaMKII 
T286, an effect abolished in the presence of an inhibitor of CaMKII (CI, 10 µM, 30 minutes) but 
the inhibitor RAF inhibitor GW 5074 (GW, 1 µM, 30 minutes) or two MAPK inhibitors PD 98059 
(PD; 25 µM) and UO126, (UO, 10 µM), both drugs added for 30 minutes. B. The CORT-induced 
phosphorylation of ERK 1/2 was also reduced by inhibitors of CaMKII and RAF and abolished by 
both MAPK inhibitors. C. The phosphorylation of CREB induced by CORT was abrogated by the 
inhibitors of CaMKII, RAF and ERK 1/2.  
The Western blot images shown are representative of results from at least 3 independent 
experiments. *: P<0.05, **: P<0.001 vs untreated (CON) cells.  #: P<0.05, ##: P<0.001 vs 
CORT-treated cells.   
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5. DISCUSSION 
Glucocorticoids (GC) are the main hormonal mediators of stress. In addition to 
assuring physiological adaptations (e.g. glucose mobilization and immuno-
suppression), GC influence behavior through actions exerted directly on neurons. 
For example, GC can affect neuronal birth, differentiation and survival as well as 
alter dendritic arborization and synaptic activity in a number of brain regions, 
including the hippocampus, amygdala and prefrontal cortex. Further, GC actions 
in both the brain (prefrontal cortex, hippocampus and hypothalamus) and 
pituitary are important regulators of the endocrine response to stress, including 
its curtailment once the stressor is no longer present. In most cases, GC serve 
an adaptive function, but in some circumstances (e.g. when their levels remain 
high for long periods), they can cause damage in peripheral and neural tissues. 
For this reason, they are of particular interest in the filed of psychiatry because 
mood and anxiety disorders are closely associated with elevated levels of 
glucocorticoids in patients.  
 
The long-term actions of GC are mediated by nuclear receptors, the 
glucocorticoid (GR) and mineralocorticoid (MR) receptors. These receptors are in 
fact ligand-activated transcriptional factors. Most studies on GC actions relate to 
their transcriptional effects that eventually lead to the de novo synthesis of 
proteins from about one hour after arrival of the GC signal. On the other hand, 
research in the last two decades has indicated that GC, like some other steroid 
hormones whose actions are also normally mediated through nuclear receptors 
(the best example is the estrogen, estradiol), induce rapid changes in neural 
activity as well as in behavior. Most of the studies have involved 
electrophysiological recordings but several have also shown that plasma 
membrane-proximal signaling cascades can be activated within a few minutes of 
GC application. Such signaling mechanisms that do not immediately involve 
gene transcription and protein synthesis are referred to as the rapid or non-
genomic actions of GC. The purpose of the work described in this thesis was to 
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obtain more detailed information concerning the mechanisms that rapidly 
transduce GC signals from the cell membrane. 
 
Primary neuronal cultures from the rat were chosen as the model to investigate 
the fast signaling cascades triggered by GC. The hippocampus is widely used for 
such studies because it is a known target of GC actions in the brain, in particular 
the central control of activity of the hypothalamo-pituitary-adrenal (HPA) axis and 
behavioral functions such as learning and memory. On the other hand, the 
hippocampus strongly expresses the GC-activated nuclear receptor (GR), a fact 
that, in some ways, compromised the use of this cellular model to understand GC 
actions that might not involve these receptors; this limitation was overcome 
however by the use of potent antagonists of the nuclear GR (e.g. RU 38486, 
J2700 and the novel CORT 108297 from Corcept Therapeutics).  In fact, all of 
the investigations reported in this thesis were based on pharmacological 
approaches. Although the use of certain genetic manipulations were considered, 
these were not feasible primarily because of the difficulties associated with 
introducing genes by transfection into post-mitotic neurons. At the analytical level, 
besides the use of confocal microscopy for verification purposes, the studies 
were mainly carried out by immunoblotting. Such methods are standard for the 
analysis of kinase signaling pathways, in particular the phosphorylation of 
substrate proteins since cells can be rapidly lysed in phosphatase inhibitor-
containing buffers to prevent spontaneous dephosphorylation. Another approach 
sometimes used to detect phosphorylated proteins is enzyme-linked immuno-
adsorbent assay (ELISA). While ELISA provides relatively high throughput 
quantitative measurements, its cost is a major limiting factor. Fluorescence 
resonance energy transfer assays (FRET) and time-resolved fluorescence 
assays may also be used to study cell signaling, but such methods lack sufficient 
throughput. Phospho-proteomics, based on mass spectrometry (MS), probably 
represents the best state-of-the-art approach; however, sample preparation is 
tedious and the assays have low throughput and require significant 
bioinformatics support.  
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The present study provides a comprehensive description of the signaling 
cascade set in motion by non-classical glucocorticoid signaling and report the 
functional consequences at hippocampal neuronal synapses. In this work, a 
cascade of events was identified, namely, a membrane phase, a divergent early 
signaling phase, a convergence phase resulting in activation of a “hub” of 
tyrosine kinases, and a late-divergent phase during which tyrosine kinases 
influence multiple downstream effectors and targets to finally alter NMDA 
receptor function and the actin cytoskeleton.  
Although the rapid effects of steroids have been shown to share some common 
secondary signaling pathways (Hammes and Levin, 2007), detailed studies of 
intracellular pathways involved in the rapid actions of steroids, and 
corticosteroids in particular, in neurons are still poorly understood.  For example, 
several groups have observed that the phosphorylation of ERK 1/2 can be rapidly 
(within minutes) induced by the stimulation of aldosterone, corticosterone, 
estradiol, androgens and vitamin D in (mostly) non-neuronal cells or in an 
undifferentiated neural (PC12) cell line (Qiu et al., 2001; Pedram et al., 2007; 
Grossmann and Gekle, 2009).  It has been shown that all three members of 
MAPK family (ERK 1/2, JNK and P38) can be activated by CORT or membrane 
impermeable CORT conjugated to BSA (CORT-BSA) in cultured rat embryonic 
hippocampal neuronal cells; these effects are seen at concentrations ranging 
from 10-10 to10-7 M, occur within 15 minutes and cannot be blocked by 
antagonists of the classical (nuclear) GR (RU38486) or MR (spironolactone). 
Also, they occur even in the presence of protein synthesis inhibitor 
(cycloheximide, CHX), strongly implicating the involvement of MAPK activation 
and demonstrating that these effects do not directly involve activation and/or 
repression of genes. Rather, it has been hypothesized that these effects are 
mediated by novel membrane-bound receptors, rather than classical GR or MR 
(Xiao et al., 2005). Moreover, researchers from latter group also suggested that 
G-protein and PKC, but not PKA, are part of the intracellular signal transduction 
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pathways that are induced by CORT or CORT-BSA, at least in the case of MAPK 
activation (Qi et al., 2005).  
 
This work was started by carrying out a series of dose-response and time course 
experiments to examine how CORT acts in rapid mode to influence intracellular 
signaling cascades in postnatal rat hippocampal neuronal cells (dissociated 
cultures). By these experiments, it was intended to reproduce some of the earlier 
work in non-hippocampal cells and to test the suitability and applicability of our 
cellular model. In that work, the focus was on a key member of the MAPK family, 
ERK1/2. Cultures were treated with CORT and ERK phosphorylation was 
measured as the end-point. It was found that within 20 minutes of treatment, 
CORT   at a dose of 10 nM induced maximum activation of ERK 1/2. A similar 
pharmacological profile was obtained with membrane-impermeable CORT-BSA.     
Importantly, the presence of CHX did not alter the activation of ERK 1/2 induced 
by CORT. Additionally, another researcher from our laboratory found that CaMKII, 
an upstream regulator of MAPK (Fig 4.27), can also be activated by CORT within 
20 minutes in rat hippocampal slices, and that these effects are blocked by 
neither CHX nor the transcriptional inhibitor anisomycin (T. Riedemann, 
unpublished data). Thus, the non-genomic MAPK activation induced by CORT 
can be reproduced in hippocampal neurons, allowing further investigations of the 
potential mechanisms or pathways through which they may be mediated.  
 
A comment regarding the use of steroid-BSA conjugates in implications of 
membrane receptor-mediated of a steroid is required at this point. As noted by 
Chambliss at al., (2010), such preparations may contain traces of free 
(unconjugated) steroid and may be biodegradable over time. Further, other 
authors (Stevis et al., 1999; Temple and Wray, 2005) have noted that the high 
molecular weight conjugates that result from conjugation, together with the fact 
that the linked BSA may mask the steroid’s ability to bind to ligand-binding sites 
on the cognate nuclear receptor. It should be noted that, despite these criticisms, 
steroid-BSA conjugates (e.g. CORT-BSA) remain a standard tool until 
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dendrimers of CORT and other steroids, such as those being developed for 
estrogen (Chambliss et al., 2010) become available. While the limitation of free 
steroid contaminants should not be disregarded, the fact that conjugated steroids 
may not be able to bind to their corresponding nuclear receptor(s) would, actually 
be an advantage in the type of investigations performed in this thesis since they 
would exclude the participation of nuclear receptors. The problem of 
biodegradability is an important one (especially with respect to pre-pared 
conjugates, but this issue is not easily resolved given the cost and difficulties 
involved in consistently preparing conjugates with a pre-defined steroid-BSA ratio. 
On the other hand, since the present experiments were carried out with the aim 
of following signaling processes initiated within 20-60 minutes, the degradation of 
the complex after addition to cultured cells (lacking all the normal degradation 
and detoxification mechanisms found in the live animal) would be expected to be 
minimal. Lastly, it should be mentioned that being haptens, steroids need to be 
covalently linked to BSA, using linkers such as thyroglobulin, O-carboxy-methyl-
oxime (CMO), or hemi-succinate; in our case, CORT was conjugated to BSA via 
CMO.  
 
Together with the results obtained with CORT-BSA and CHX, our data point to 
the possibility that the fast actions of CORT are non-genomic and that CORT 
most likely initiate signaling through non-classical (non-nuclear) membrane-
bound receptor(s). On the other hand, electron and confocal microscopy 
approaches led to the description of postsynaptic membrane-bound classical GR 
(Johnson et al. 2005) and MR (Prager et al. 2010) in the neurons in the rat 
amygdala. These findings complement with other reports that CORT induces 
neurotransmitter release and modulates synaptic plasticity through receptors 
which are sensitive to antagonists of classical MR and/or GR (Komatsuzaki et al., 
2005; Wang and Wang, 2009). Also worth noting is the work by Joëls and 
colleagues which suggests involvement of classical GR and MR in the 
electrophysiological actions of CORT; in those studies, the authors used mouse 
mutants in which either the nuclear GR is non-functional due to deletion of the 
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dimerization domain of the receptor (Karst et al., 2000) or in which the MR gene 
was knocked out (Karst et al., 2005; Olijslagers et al., 2008). The subject of 
whether classical (nuclear) receptors might mediate steroid signaling initiated at 
the membrane remains highly controversial at present and the subject of 
intensive research, especially with respect to membrane mediators of the 
estrogen actions (Maggiolini and Picard, 2010; Chambliss et al., 2010). 
Questions remain about whether the membrane receptor shares identity with 
nuclear receptors and, if so, how receptors that are normally localized in the 
nucleus (or are translocated there after ligand activation, as in the case of the GR) 
are trafficked and inserted into the membrane – the latter seems unlikely from a 
biophysical perspective.  
 
At least in the present work (and similar to some other studies, e.g. Qi et al., 
2005; Xiao et al., 2005; Hu et al., 2010; Xiao et al., 2010), the rapid actions of 
CORT were not subject to blockade with antagonists of the classical nuclear 
receptors (MR and GR). It should be noted that in each case, three structurally 
distinct antagonists were examined (GR: RU38486, J2700, CORT 108297; MR: 
RU28318, spironolactone, eplerenone). Additionally, classical GR-unrelated 
effects, that could not be antagonized by GR antagonists, have been reported at 
the cellular (Di et al., 2003; 2009) and behavioral (Sandi et al., 1996a; Mikics et 
al., 2005) levels. Those effects could be potentially mediated by a G protein-
coupled receptor (GPCR) since G-proteins have been shown to take part in other 
rapid effects of CORT (Ffrench-Mullen, 1995; Qi et al., 2005; Hu et al., 2010). In 
an elegant set of studies, using fluorescence correlation spectroscopy, Maier et 
al., (2005) showed that binding of fluorescein-labeled dexamethasone (a 
synthetic potent glucocorticoid that normally shows high selectivity for nuclear 
GR) on cell membranes of the mouse pituitary cell line (AtT20) sensitive to 
pertussis toxin (PTX), a G-protein inhibitor, but not the GR antagonist RU38486. 
These results provide strong evidence of high affinity binding (Kd of 1.8 nM) of 
glucocorticoids on cell membranes and that this binding requires G-proteins. 
However, this study did not examine whether G-proteins are required for the 
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triggering of intracellular signaling cascades downstream of the putative 
membrane receptor.   
 
More recently, GPR30, a GPCR originally suggested to mediate estrogen effects 
and localized in the membranous endoplasmic reticulum (Thomas et al., 2005; 
Revankar et al., 2005), was identified as a possible mediator of the rapid 
signaling induced by aldosterone (a steroid closely-related to CORT and the 
natural ligand of the classical MR) in endothelial cells. Briefly, Gros et al., (2011) 
showed that the activation of ERK induced by aldosterone could be inhibited by 
an antagonist of GPR30 and suggested GPR30 might be an alternative 
aldosterone receptor (Gros et al., 2011).  The previous work on GPR30 as a 
mediator of estrogen actions has raised much debate, with some authors 
claiming that it does not display any properties expected of an estrogen receptor 
(Otto et al., 2008). However, an emerging view is that GPR30 acts as a 
collaborator of estrogen receptor in signaling cascades and may also function 
downstream of cellular events induced by steroid compounds which are certainly 
not mediated by classical receptors (Levin 2009; Langer et al., 2010). Although 
most studies related to GPR30 were performed in carcinoma cell lines, the 
expression of GPR30 has been reported to be abundant in rodent brain, 
especially in hippocampus (Matsuda et al., 2008; Hazell et al., 2009).  
 
In this work, the GPR30 antagonist (G-15) significantly prevented the rapid 
effects induced by CORT and CORT-BSA, adding support for the view that this 
GPR30 has a mediatory role in the activation of membrane-proximal signaling 
cascades by CORT. Attempts here to localize GPR30 in hippocampal neurons 
however failed; this could be because of need to further optimize immunostaining 
and cell fixation conditions. On the other hand, since it was reported that other 
types of cultured cells tend to express less GPR30 with increasing time in culture 
(Chambliss et al., 2010), caution will still be needed in interpreting results that 
indicate GPR30 mediation of effects observed. Nevertheless, this discussion will 
proceed on the assumption that technical difficulties contributed to the failure to 
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detect the protein in our hippocampal neuronal cultures, especially in light of 
evidence shown in this study that PTX blocks the rapid actions of CORT, a result 
that implies a role of G (Gi/o) proteins, as shown in Fig 4.15 and Fig 4.16.   
 
Here, protein tyrosine kinase (PTK) was considered a good candidate to 
investigate as a starting point for the potential secondary signaling cascades 
which potentially mediate non-genomic signal transduction by CORT. Previously, 
the mediatory role of PTK, such as Pyk2 and Src, were shown be involved in the 
signaling pathways triggered in GPCR-dependent MAPK activation in PC12 cells 
(Dikic et al., 1996) and hippocampal slices (Corvol et al., 2005). The results of 
the present research (Fig 4.6A) showed that CORT rapidly induces a global 
increase of tyrosine phosphorylation levels in hippocampal neuronal cells. These 
effects were not affected by pretreatment with CHX (Fig 4.6B), suggesting a 
crucial role of tyrosine kinase in execution of the non-genomic effects of CORT.  
This finding prompted us to next analyze the specific tyrosine kinases involved.  
Earlier studies have reported that activation of divergent second messengers (e.g. 
Ca2+) and classical pathways (e.g. PKC, PKA and PI-3K/PKB) can converge to 
produce full activation of the scaffold tyrosine kinase Pyk2. Notably, Ca2+- and 
PKC-dependent mechanisms were described to be fundamental for the activation 
of Pyk2 in multiple contexts (Della Rocca et al., 1997; Avraham et al., 2000; 
Huang et al., 2001), Pyk2 being a key player in neuronal signaling mediated by 
various GPCR (MacDonald et al., 2005; Sayas et al., 2006; Gaddini et al., 2009; 
Nicodemo et al., 2010; Yang et al., 2010). In the present study, CORT was 
shown to regulate the activation of Pyk2 at several “checkpoints”. Specifically, 
the steroid induced PKC-dependent autophosphorylation of Pyk2, regulated the 
inhibitory control of PTP-PEST by PKB and PKA (Fig 4.13), and influenced the 
phosphorylation of the C-terminal interaction domain (focal adhesion targeting 
domain) of Pyk2 via PKA through additional, but as yet unknown mechanisms. In 
this context, it is interesting that the simultaneous activation of multiple, 
converging pathways was shown by other authors to contribute to the strong 
phosphorylation of Pyk2 in synapses (Huang et al., 2001; Hsin et al., 2010); 
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based on those findings it appears that CORT may cause a sudden low-to-high 
switch in Pyk2 activity, thus allowing it to serve as a regulator of metaplasticity. 
The convergence of multiple signaling pathways on Pyk2 confers to this non-
receptor tyrosine kinase a major role in integrating multiple signaling inputs, in 
particular allowing a strong interaction with other pathways (e.g. those from 
neurotransmitter receptors), leading to PKA or PKB activation. Taken together, 
these results represent new levels of integration of rapid CORT signaling with 
other cascades; previously, such convergence of CORT signaling has been 
restricted to transcriptional regulation (Schmidt et al., 2001).  
On the other hand, activated Pyk2 serves as a major divergence point in the 
signaling cascades: Pyk2 not only functions as kinase that phosphorylates a 
number of substrates, adaptors and other kinases but it also acts as a scaffold 
protein to trigger the formation of transduction complexes (Avraham et al., 2001). 
In the present study, both Src kinase and c-Abl kinase were phosphorylated upon 
treating hippocampal neurons with CORT; these effects were dependent on Pyk2 
activation (Fig 4.9B and Fig 4.19B). Interestingly, Src kinase was found to 
involved in an amplification loop: after phosphorylation of Src by Pyk2 auto-
phosphorylation, phosphorylated Src in turn, led to further kinase activity on other 
residues in Pyk2 kinase and scaffold domains (Fig 4.11), as was described 
before for other system (Avraham et al., 2001; Park et al., 2004).  
Since synapses are enriched with Pyk2, it seems likely that the Pyk2/Src module 
may be an important modulator of synaptic physiology. In line with this view, 
Cheung and Gurd (2001) reported that the cytoplasmic tail of the NR2 subunit of 
NMDAR to be a major target of tyrosine phosphorylation. Among several tyrosine 
phosphorylation sites, the tyrosine 1472 (Y1472) site of the NR2B appears to be 
a crucial regulator of NMDAR endocytosis since it provides the binding site for 
the endocytic adapter AP1 (Roche et al., 2001; Prybylowski et al., 2005). 
Accordingly, plasticity-inducing stimuli trigger Pyk2 activation, following Src 
activation, leading to major changes in the amount of surface NMDAR (Huang et 
al., 2001; Heidinger et al., 2002; Hsin et al., 2010). As shown in Fig 4.22, CORT 
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induces a marked increase in synaptic surface-localized NMDAR, an effect that 
involves increased phosphorylation of NR2B Y1472; both CORT-induced events 
were required the Pyk2/Src cascade (Fig 4.23). These findings provide molecular 
evidence to explain the previously-reported fast actions of CORT on 
electrophysiological activity of hippocampal neurons (Takahashi et al., 2002).  
An interesting result obtained in this work was that CORT caused a significant 
increase in levels of phosphorylated CaMKII at its threonine 286 site within just a 
few minutes of application; phosphorylation of this site has been described to 
result in persistent activation of CaMKII (Yang and Schulman, 1999). A similar 
effect was observed in other work on hippocampal acute slices in our laboratory 
(T. Riedemann, unpublished). Since CaMKII serves to regulate ERK/MAPK (Liu 
et al. 2009), it is interesting that in this present study, CORT-induced 
phosphorylation of ERK 1/2 could be blocked by an inhibitor of CaMKII (Fig 
4.27B). Furthermore, inhibitors of both CaMKII and MAPK attenuated the 
activation of cAMP response element-binding protein (CREB) induced by CORT 
(Fig 4.27C), indicating that CORT-triggered transcriptional events occur through 
a CaMKII-MAPK-CREB pathway; a similar pathway was identified in PC12 cells 
(Banno et al., 2008). Lastly, CORT led to increased expression of early growth 
response-1 (Egr-1) expression in hippocampal neuronal cells (Fig 4.28), a 
MAPK-regulated transcription factor that is also considered to be a target of 
classical GR (Revest et al. 2005; Benz et al., 2010).. 
NMDAR play a critical role in the regulation of synapse plasticity, effects that are 
mediated by CaMKII (Barria and Malinow, 2005) and ERK1/2 (Kaphzan et al., 
2006). In the work describe in this dissertation, NMDAR antagonists abolished 
CORT-induced activation of both CaMKII and ERK1/2, implying that CORT can 
also impact on the NMDAR- regulated CaMKII-MAPK-CREB pathway. These 
observations indicate that CORT signaling can cause transactivation of the 
NMDAR, setting the stage for the convergence and integration of intracellular 
signals that ultimately regulate gene transcription.  
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Further studies undertaken as part of this research aimed at gaining an insight 
into the functional meaning of the above results. The C-terminal interaction 
domain of Pyk2 contains binding sites for several adaptor proteins, including 
RhoGEF (Ying et al., 2009), the vav/sos complex (Gao and Blystone, 2009) and 
c-Abl (Zrihan-Licht et al., 2004). It was decided to first focus on RhoA, a member 
of the Rho family, implicated in the  regulation of various cellular processes and, 
in particular, the actin cytoskeleton (Hall, 1998; Etienne-Manneville and Hall, 
2002). The actin cytoskeleton is the major structural component of both pre- and 
postsynaptic synapses (spines). Dynamic changes in the actin cytoskeleton are 
believed to be mainly responsible for the morphological changes that accompany 
synaptic plasticity, usually measured in terms of presynaptic neurotransmitter 
release and altered postsynaptic electrophysiological activity. In addition the actin 
cytoskeleton plays an important role in the exo- and endocytic trafficking and 
anchorage of receptors such as NMDAR at the synaptic surface (Dillon and 
Goda, 2005; Cingolani and Goda, 2008; Roselli et al., 2011). In the present 
investigation (Fig 4.21), CORT induced activation of RhoA, an effect that was 
blocked by inhibitors of G-protein, Pyk2 and Src. However, inhibition of c-Abl, 
another actin-regulating pathway, did not interfere with the effects of CORT on 
RhoA activity. Similar findings were reported in another study on rat hippocampal 
neuronal cells in which a glutathione S-transferase pull-down approach was used 
for analysis (Jones et al., 2004). These observations therefore suggest that the 
Rho pathway either acts independently or in cooperation with c-Abl kinases.  
 
As a powerful regulator, c-Abl has been shown to integrate multiple signals to 
regulate the actin cytoskeleton through the phosphorylation of Wiskott–Aldrich 
syndrome protein (WASP) and WASP-family verprolin-homologous protein 
(WAVE) complexes (Woodring et al, 2003; Colicelli, 2010). The clinical relevance 
of c-Abl is reflected in the fact that it was identified as a potent Tau kinase; Tau 
hyperphosphorylation represents a neuropathological hallmark of Alzheimer’s 
disease pathology (Schlatterer et al., 2011), and was shown in our laboratory to 
mediate the effects of adverse effects of stress on neuronal structure and 
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function thus also implicating it causally in depression (Catania et al., 2009; 
Sotiropoulos et al., 2011). Additionally, recent evidence suggests that c-Abl can 
modulate the clustering of postsynaptic density (PSD) proteins (de Arce et al., 
2010). In this study, it was seen that c-Abl is activated by CORT via a cascade 
originating at Pyk2, but independently of the NMDAR-triggered cascade (Fig 
4.19). Compared to the activation of Pyk2 and Src by CORT, phosphorylation of 
c-Abl appears with a slight delay. Use of STI571, a highly specific inhibitor pf c-
Abl, revealed at least two sets of changes that may be attributed to signaling 
through c-Abl: as shown in Fig 4.20, the remodeling of the actin cytoskeleton (as 
revealed by altered clustering and localization of drebrin) and increased 
clustering of PSD-95, a key synaptic protein that serves to maintain PSD 
structure and couple receptors with signaling modules (Roselli et al., 2005). The 
results obtained this suggest that the reported fast actions of CORT on spine 
morphology (Komatsuzaki et al., 2005) may be due to its ability elicit intracellular 
signaling pathways that underlie actin remodeling and PSD-95 clustering. It 
should be noted that PSD-95 reportedly interacts with several non-receptor 
tyrosine kinases, including Pyk2 and Src (Seabold et al., 2003) and may thus 
serve as an additional point of integration of PTK signaling. 
 
A schematic, representing the main steps through which CORT can elicit rapid 
responses from hippocampal neurons is summarized in Figure 5.1. The model 
proposes that CORT interacts with a putative membrane GPCR (GPR30), which, 
through Gi/o protein-dependent mechanism transduces the signal into cytoplasm. 
Besides increasing of intracellular Ca2+ levels, autophosphorylation of Pyk2 at its 
Y402 residue occurs via the PLC/PKC pathway. This is followed by 
autophosphorylation of the Src kinase at its Y416 site which, in turn, facilitates 
full activation of Pyk2 through phosphorylation of its Y579/580 and Y881 residues 
under the control of PTP-PEST; PI-3K/PKB and PKA pathways participate in the 
latter. Ultimately, activated Pyk2/Src kinases trigger multiple downstream 
signaling mechanisms including RhoA and c-Abl; among other functions, the 
latter serves to regulate dynamics of the actin cytoskeleton and PSD-95 
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clustering, as well as NMDAR cascades. Acting through the CaMKII pathway, 
NMDAR-mediated signaling activates MAPK, eventually impacting on 
transcriptional factors such as Egr-1 and CREB.  
 
 
 
 
The present dissection of membrane-initiated signaling by CORT signaling in 
neurons has added new information to the field. It has led to interconnections 
between a putative GPCR for CORT to a major signaling hub; the latter, 
comprised of non-receptor tyrosine kinases links to downstream functional 
targets such as NMDAR and the actin cytoskeleton, through to transcriptional 
events. Together, these findings demonstrate how CORT-initiated non-nuclear 
receptor-mediated pathways and events can influence synaptic function that may 
extend to complex remodeling of brain networks (Ferries and Stolberg, 2010). 
FIG.5.1 A working model to represent how CORT may induce rapid signaling events 
in hippocampal neurons, based on results obtained in the present study. 
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Notably, c-Abl can exert distinct cytoplasmic and nuclear functions (Liberatore et 
al., 2009; Colicelli, 2010) and may provide another possibility for transcriptional 
integration of classical GR and non-genomic pathways.  In a very recent study, c-
Abl has been implicated in Alzheimer’s disease pathology since it is a potent Tau 
kinase (Schlatterer et al., 2011)  
 
The identification and characterization of receptors responsible for non-genomic 
effects of corticosteroids would be an important filed to focus for the further 
studies, the better understating of secondary mechanisms of these fast 
corticosteroids effects may also deserve more attention because it may not only 
be useful to identify the pharmacological targets of clinical treatments for 
disorders in the nervous system, but also may bring hints for studies of 
mechanisms regulated other steroid hormones rapid effects. Advances in this 
direction are essential to be able to provide irrefutable arguments against claims 
that the rapid actions of CORT at the plasma surface are mediated by classical 
nuclear MR and/or GR (see review by Groeneweg et al., 2011). Recently, as 
reviewed in an instructive article by Krug et al., (2011), it has emerged that 
fragments of the classical MR may associated with the plasma  membrane 
(perhaps explaining reports of MR/GR immunoreactivity in neuronal cell 
membrane, e.g. Johnson et al., 2005; Prager et al., 2010). One idea, shown to 
apply to the estrogen receptor, is that the liganded (holo)-nuclear receptor, or 
fragments thereof, may become palmitoylated and eventually embedded in 
calveolae containing a variety of molecules, including steroid hormone receptors, 
growth factor receptors, and molecules involved in rapid steroid signalling (Krug 
et al., 2011).   
 
Lastly, it deserves mentioning that in this dissertation and in the literatures, the 
terms genomic and non-genomic signaling are often used; the term “genomic 
actions” refers to transcriptional regulation mediated by classical nuclear 
receptors, whereas those events that are triggered by membrane signaling (e.g. 
the fast or rapid actions of CORT) are considered “non-genomic actions”. Strictly, 
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this terminology is inappropriate since signals interacting with signaling cascades 
originating at the cell membrane, cytoplasm and nucleus will all ultimately 
converge to regulate gene expression. This is illustrated by the observation that 
CORT can lead to the expression of transcription factors such as CREB and Egr-
1 by activating MAPK/ERK; CREB itself can modulate GR activity through CREB 
binding protein (CPB) and p300 (Kino et al., 1999) and both CREB (Chen et al., 
2010) and Egr-1 (Lu et al., 2011) can activate cyclin-dependent kinase 5 (CDK5) 
an important kinase in neurons. Interestingly, in preliminary data obtained at a 
late stage of this study found that CORT rapidly leads to the phosphorylation of 
nuclear GR within 5 minutes (Yang and Almeida, unpublished data). Previous 
studies by Kino demonstrated that CDK5 induces phosphorylation of nucleus-
acting GR (Kino et al., 2007) and MR (Kino et al., 2010) and regulate receptor-
related transcriptional activity through physical interaction. Finally, it is relevant to 
note that the phosphorylation of CDK5 has also found to be induced by the 
activation of c-Abl (Zukerberg et al., 2000). On the other hand, data from a 
preliminary study showed that CORT rapidly (with 20 minutes) induces 
phosphorylation of GR at serine 232 (a site known to increase the transcriptional 
activity of GR) can be prevented by treatment of hippocampal neurons with 
antagonists of the classical nuclear GR (Yang and Almeida, unpublished data). 
Although these findings need to be confirmed they hint at how membrane-
mediated signals may serve to modulate the activity of nuclear receptors.  
 
In conclusion, the studies presented in this thesis indicate that extra-nuclear 
signaling initiated by CORT, serving as a “starter” of multiple kinase cascades, 
can converge on gene regulatory pathways that are activated by CORT binding 
to nuclear MR and GR. Among the many questions that remain to be tackled in 
future research, the identity of the putative membrane receptor for CORT 
remains the most important and also most challenging. 
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7. ABBREVIATIONS 
2-APB 2-Aminoethyl diphenylborinate 
Abl Abelson tyrosine kinase 
AC adenylyl cyclase  
ACTH adrenocorticotrophic hormone  
AF activation functions  
APS Ammonium Persulfate   
Arg Abl-related gene 
AVP arginine vasopressin 
BCR breakpoint-cluster region  
BSA bovine serum albumin 
CADTK calcium-dependent tyrosine kinase  
CAKβ cell adhesion kinase beta  
CaMKII calmodulin kinase II  
cAMP cyclic adenosine monophosphate 
CBG corticosteroid binding globulin  
Cdk5 Cyclin-dependent kinase 5  
Chk Csk homologous kinase  
CHX cycloheximide 
CNS central nervous system 
CNS central nervous system  
CORT corticosterone  
CORT-BSA bovine serum albumin conjugated to corticosterone 
CREB cAMP response element-binding   
CRH corticotrophin releasing hormone  
CS corticosteroids 
Csk C-terminal Src kinase  
CyD 40% cyclodextrin  
DBD DNA binding domain  
DEX dexamethasone  
dH2O Distilled water 
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DI H2O deionized  water 
DIV days in vitro  
DMSO Dimethyl sulfoxide  
DNase I Deoxyribonuclease I  
DTT Dithiothreitol  
EDTA Ethylenediaminetetraacetic acid 
EGF epidermal growth factor  
EGFR epidermal growth factor receptor  
Egr-1 early growth response-1  
ELISA Enzyme-linked immunosorbent assay  
ER estrogen receptors  
ERK 1/2 extracellular signal-regulated kinase p44/p42 
EtOH Ethanol 
F-actin filamentous-actin 
FAK focal adhesion kinase  
FAT focal adhesion targeting  
FBD F-actin binding domain  
FGF fibroblast growth factor  
FKBP FK506 binding proteins 
FREM band four point one, ezrin, radixin, moesin  
GABA A gamma-aminobutyric acid type A  
G-actin globular-actin 
GAP GTPase activating proteins  
GBD G-actin binding domain  
GC glucocorticoids 
GDI guanine nucleotide dissociation inhibitors  
GDP guanosine diphosphate  
GEF guanine nucleotide exchange factors  
GLISA G-protein linked immunosorbent assay  
GPCR G-protein coupled receptors  
G-protein GTP-binding protein  
GR glucocorticoids receptor 
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Grb2 growth factor receptor-bound protein 2 
GSK-3 Glycogen synthase kinase 3  
GTP guanosine triphosphate   
HPA hypothalamo-pituitary-adrenal  
HRE hormone response elements  
HRP horse radish peroxidase 
HSP heat shock protein  
ICC Immunocytochemistry  
JAK Janus protein tyrosine kinases  
JNK c-Jun N-terminal kinase  
kDa kilo daltons 
L liter 
LBD ligand binding domain  
LTD long-term depression 
LTP long-term potentiation  
M molar 
m meter 
MAPK mitogen-activated protein kinase  
MC mineralocorticoids 
MDR multiple drug resistance  
mEPSCs miniature excitatory postsynaptic currents  
MR mineralocorticoids receptor 
NF- κB nuclear factor-κB  
NMDA N-methyl D-aspartate 
NMDAR N-methyl D-aspartate receptor  
NOS nitric oxide synthase  
NRTK non-receptor tyrosine kinases  
PBS Phosphate-buffered saline  
PBST Phosphate-buffered saline- Triton-X100  
PDGF platelet-derived growth factor  
PDL Poly-D-Lysine  
PEP proline-enriched phosphatase  
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PEST proline-, glutamic acid-, serine- and threonine-rich family 
PI3K phosphatidylinositol-3-kinase  
PKA protein kinase A 
PKB protein kinase B 
PKC protein kinase C  
PLC phospholipase C  
PP2 (4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-
d]pyrimidine) 
PSD-95 postsynaptic density protein 95  
PTK protein tyrosine kinase  
PTP protein tyrosine phosphatases  
PTX pertussis toxin 
PVN paraventricular nucleus  
Pyk2 proline-rich tyrosine kinase 2  
RAFTK related adhesion focal tyrosine kinase  
RLU relative luminescence units  
rpm Revolutions per minute 
RTK receptor tyrosine kinases  
S serine  
SAGE serial analysis of gene expression 
SD standard division  
SDS Sodium dodecyl sulfate  
SFK Src tyrosine kinase  
SH Src homology 
Src sarcoma tyrosine kinase  
Syk Spleen tyrosine kinase 
T threonine 
TBST Tris-buffered saline-Tween-20 
TEMED Tetramethylethylenediamine 
TF  transcription factors  
Trk neurotrophic tyrosine receptor kinases  
VSCC voltage-sensitive calcium channel  
WASP Wiskott–Aldrich syndrome protein   
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WAVE WASP-family verprolin-homologous protein  
Y tyrosine 
 
ACKNOWLEDGEMENTS 
 
 - 128 -
8. ACKNOWLEDGEMENTS 
My supervisor, Dr. Osborne Almeida (Neuroadaptations Group, Max-Planck 
Institute of Psychiatry, Munich), deserves special appreciation. Osborne’s His 
generous encouragement, wide knowledge, constant support and understanding 
make the past years become some of the best time in my life. Not only did he 
teach me the ways of scientific thinking, but also the proper attitude to face the 
unpredictable future. Osborne’s mentorship will undoubtedly guide me in my 
future career and entire life.  
 
I cannot thank Dr. Francesco Roselli enough. Francesco provided excellent and 
patient supervision and introduced me to a number of biochemical and 
microscopic techniques that form the backbone of this thesis. This work gained 
much from his wide and insightful knowledge that always served to “rescue” even 
the most frustrating experiments! Francesco’s rapid and intelligent suggestions – 
even after he had moved to Basel – merit admiration and special thanks.   
 
I would also like to thank Prof. Dr. Rainer Landgraf for accepting to support me 
through my studies as a PhD student at the Ludwig-Maximilians-Universität 
München; without his kind advice and support the final stages of my PhD studies 
would not be possible.  
 
Others in the Neuroadaptations Group also contributed to my studies and 
deserve special thanks. Dr. Shuang Yu was always patient and encouraging and 
enthusiastically introduced me to neurobiological experiments. Her guidance and 
encouragement helped me bridge difficult periods. I would also like to express 
sincere gratitude to Dr. Alexandre Patchev and Therese Riedemann for their 
many suggestions and criticism that helped improve the design and interpretation 
of my experiments. I am very thankful to Dieter Fischer and Rainer Stoffel for 
their always friendly help and advice and for contributing to the smooth lab 
environment.  
ACKNOWLEDGEMENTS 
 
 - 129 -
I am deeply thankful to Frau Carola Hetzel for her kindness, optimism and ever-
ready-to-help attitude. Carola, you really helped to make my lonely life abroad so 
much better! 
 
I would like to thank Prof. Dr. Dr. Dr. h. c. Florian Holsboer for enabling me to 
complete my studies by providing generous resources and the opportunity to 
work in this excellent Institute.  
 
Finally, I would like to thank my most beloved parents, Dr. Bo Yang and Jianrui 
Liu, for their consistent love and belief in me, as well as my uncle, Prof. Ze Yang, 
for his encouragement and guidance. I would not be here without them. And I 
deeply grateful to my girlfriend, Huan Chen; she was there at all the right 
moments, giving me enormous support and comfort. Although she could not join 
me in Munich, I always felt her love and encouraging spirit. 
CURRICULUM VITAE 
 
 - 130 -
CURRICULUM VITAE 
Given Name: Silei                           Family Name: Yang  
Date of Birth: December 20, 1978  
Place of Birth: Tieling, Province of Liaoning, P. R. China  
E-mail:  sileiyang@ yahoo.com 
 
Education  
2007.09 - Present  Ph.D. student,  
Max Planck Institute of Psychiatry, Munich  
supervised by Prof. Dr. Rainer Landgraf  and Dr. Osborne Almeida;  
registered for PhD degree from Ludwig-Maximilians-Universität 
München 
 
2002.09 – 2003.07  Master degree,  
Majored in Molecular Medicine and Genetic Epidemiology  
University of Pavia, Italy 
1997.09 – 2001.07 Bachelor degree,  
Majored in Biochemistry Engineering, 
Minzu University of China, China  
 
Experience  
2006.10 - Present  Ph.D. student  
Neuroadaptations Group (Head: Osborne Almeida) 
Max Planck Institute of Psychiatry, Munich, Germany  
2005.03-2006.08 Research Assistant 
International Joint Cancer Institute 
Second Military Medical University, Shanghai, China 
2003.08 – 2006.07 Research Assistant  
Department of Medical Genetics,  
National Institute of Geriatrics, Beijing, China  
2002.10 - 2003.07 Research Assistant  
Laboratory of Genetic Epidemiology 
Department of Scienze Sanitarie Applicate e Psicocomportamentali,  
University of Pavia, Pavia, Italy 
2002.02 - 2002.07 Research Assistant  
Department of Medical Genetics,  
National Institute of Geriatrics, Beijing, China 
 
CURRICULUM VITAE 
 
 - 131 -
Publications 
 
Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H, Yang S, Dai J, Wu M, Guo Y.TIP30 
inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in 
combination with 5-FU. Hepatology. 2006 Jul;44(1):205-15. 
 
Yang S, Patchev AV, Roselli F, Almeida OFX (in preparation). Signaling 
pathways downstream of the rapid actions of glucocorticoids mediated by 
putative membrane receptors. (In preparation) 
 
Yu S, Yang S, Holsboer F, Sousa N, Almeida OFX (2011) Glucocorticoid 
regulation of astrocytic fate and function. PLoS One. 6:e22419. 
 
 
 
